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ABSTRACT
DEFINING THE IMPORTANCE OF THE HNRNP I INTERACTION TO THE
SINDBIS VIRUS SUBGENOMIC VIRAL RNA USING AN INNOVATIVE
TETHERING APPROACH
Claire Westcott
July 28th, 2022
Old World alphaviruses cause significant outbreaks of illness and
debilitating multi-joint arthritis for prolonged periods. Currently, there are no FDA
approved vaccines or antiviral therapies; and thus, there is a critical need to identify
and characterize the molecular biology of alphaviruses. Alphaviruses rely on the
host cell machinery to complete the viral lifecycle and are dependent on
interactions with host RNA binding proteins. Accordingly, several host
heterogenous nuclear ribonucleoprotein proteins (hnRNPs) have been found to
bind to the Sindbis virus (SINV) RNAs. Disrupting the interaction sites in the viral
RNAs of these RNA:Protein interactions results in decreased viral titers in tissue
culture models of infection. Nonetheless, whether the observed phenotypes were
due to loss of hnRNP binding, or the incorporation of polymorphisms into the
primary nucleotide sequence of SINV remained unknown.
To determine if the loss of hnRNP binding was the primary cause of
attenuation, or if the disruption of the RNA sequence itself was responsible for the
observed phenotypes, we utilized an innovative protein tethering approach to
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restore the binding of a candidate hnRNP protein in the absence of the native
interaction site. Specifically, we reconstituted the hnRNP I interaction with the viral
RNA by replacing the native interaction site with the 20nt Bovine Immunodeficiency
virus Transactivation RNA Response element (BIV-TAR). Importantly, the BIVTAR element will bind with high specificity to proteins tagged with a TAT peptide.
Reestablishment of the hnRNP I:vRNA interaction via the BIV-TAR / TAT tethering
approach restored the phenotype to wild-type like levels. As the reconstitution of
the hnRNP I interaction in the absence of the native interaction site repaired the
mutant phenotype we can conclude that hnRNP I binding, and not primary
sequence, is responsible for the observed mutant phenotype following the loss of
the native interaction site. Further examinations of the mutant phenotype revealed
that the increased structural protein expression observed following the loss of
hnRNP I binding led to an apparent overwhelming of the host glycosylation
machinery which in turn caused poor viral particle function as manifested by
decreased specific infectivity.
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CHAPTER 1
INTRODUCTION
Alphaviral Infections and Pathogenesis
Alphaviruses are single-stranded positive sense RNA viruses that are
transmitted to vertebrate hosts primarily by mosquitoes, and thus are referred to
as arthropod borne viruses or arboviruses (1, 2). Typically, alphaviruses infect
small mammals and birds, however, notable outbreaks of disease in large
mammals such as equines and humans have happened. Large scale outbreaks of
alphaviruses infecting thousands or more were first reported in the 1920’s, and
have happened every decade since then, becoming increasingly larger and more
frequent. This is, at least in part, due to the expansion of mosquito populations to
new areas as a result of climate change and human interventions (3-5). Belonging
to the family Togaviridae, the alphaviruses are classified into two groups, the Old
World and the New World, based on their geographic location and distributions. In
addition, the Old World and New World viruses differ in the disease manifestations
they cause. Along with the initial febrile disease, the Old World (OW) alphaviruses,
such as Chikungunya virus (CHIKV), Semliki Forest Virus (SFV), and Ross River
Virus (RRV), can cause debilitating arthritis in multiple joints which persists months
to years after the resolution of acute infection (6-8). Infections of the encephalitic
New World (NW) viruses Venezuelan Equine Encephalitis Virus (VEEV), Eastern

1

Equine Encephalitis Virus (EEEV), and Western Equine Encephalitis Virus
(WEEV) exhibit higher mortality and can cause severe neurological sequelae in
those that survive initial encephalitic infection (9). Sindbis Virus (SINV) is the
infectious agent for diseases like Pogosta, Ocklebo, and Karelian fever, all which
are hallmarked by severe arthralgia-like disease; however phylogenetic analyses
indicate that it is genetically similar to the NW alphaviruses (10-12). Despite being
an arthritogenic alphavirus, SINV is used as a model system for encephalitic
infections in mice due to its apparent neurovirulence in vivo.
While there are promising candidates for therapeutics and vaccines against
alphavirus infections, unfortunately none are currently FDA approved and
alphaviral vaccines in the past have exhibited low efficacy and high reactogenicity.
Furthermore, not all broad-spectrum immunosuppressant treatments are
appropriate for alphaviral infection, as treatment with tumor necrosis factor (TNF)
inhibitors makes inflammation worse by reducing the overall control of infection
(13-17). Currently, patients infected with alphaviruses take medicine to treat the
symptoms of the underlying disease, like antipyretics, steroids, or non-steroidal
anti-inflammatory drugs (NSAIDs), as well of antirheumatic drugs when NSAIDs
are not sufficient (18-21).
Nevertheless, due to elucidation of alphaviral infections and new
technologies, there are many anti-viral strategies in clinical trials. Due to the ability
of alphaviruses to infect new mosquito species, and the low level of population
immunity, outbreaks are becoming more prevalent .Thus, alphaviruses have
become a prime candidate for the development of new anti-viral strategies. Many
2

of these new compounds target genome replication by targeting the viral replicase
components nsP1, nsP2, nsP3 and nsP4, as well as viral entry by targeting the
glycoproteins (22-25). Some possible antiviral therapeutics target the host side by
either inducing the innate immune response or prohibiting host proteases needed
to complete the viral lifecycle (26-29). However, many of these therapeutic
compounds are impractical due to cost to manufacture and distribute, low efficacy,
and off target effects to the host.
As well as these novel small compound therapeutics, there are many
candidate vaccines for alphaviruses. These vaccines are at various stages in
development and represent a wide range of strategies; there are inactivated whole
virus vaccines, several live-attenuated candidates, measles-vectored vaccines,
viral-like particle vaccines, and an emerging mRNA vaccine. The majority of
countries / regions afflicted by the alphaviruses are middle- to low-income, and the
perfect candidate should be easy and cost-effective to produce and store, as well
as distribute and administer (30-36)As well as the logistical problems, many
therapeutics and vaccine candidates will fail clinical trials as some candidates will
have adverse effects, reactogenicity, and vaccine-induced disease. Furthermore,
the extent to which immunity is maintained in the host and whether antibody
dependent enhancement will contribute significantly to alphaviral disease remains
unknown. This is due to the lack of answers to crucial questions as to how the
immune system plays a role in arthritic or encephalitic disease. Thus, there is still
a strong need to molecularly characterize alphaviruses and alphaviral infections.
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Molecular Lifecycle Overview
Alphavirus infection begins as the viral glycoproteins E1 and E2, which are
prominently displayed on the outside of the virion as a trimeric spike of
heterodimers, bind to the receptor that is on the host cell membrane via the
ectodomain of E2, as shown in Figure 1.1. The specific cell host receptor(s)
depends on the alphaviral species and host cell, and there can be multiple
receptors for one alphavirus species (2, 37). Interaction with the receptor results
in viral uptake into the cell by receptor mediated endocytosis (38, 39). As the viruscontaining endosome matures, an ATP-dependent proton pump causes it to
acidify, which is critical for a major conformational change of the glycoproteins,
causing the viral particle to undergo fusion with the endosomal membrane via the
fusion peptide of the E1 glycoprotein. The result is the release of the nucleocapsid
core into the host cytoplasm, which then disassembles to release the viral RNA
(vRNA) for translation (40-43). Disassembly of the core and consequent protein
translation is not well understood; however, host protein engagement and
relocalization to the ribosomes are known to be critical for a successful lifecycle
(44-46). First, after the release of the viral RNA, the alphaviral nonstructural
polyprotein, P1234, is translated from the newly bare vRNA as well as a P123
polyprotein due to slippage at the Opal stop codon. After synthesis the nsP2
component of the polyprotein (and individually in isolation as a monomer)
proteolytically cleaves off nsP4 (47). The polyprotein P123 and the RNAdependent RNA Polymerase nsP4 form to make the initial replicase complex that
synthesizes the minus strand RNA, which serves as the template for replication
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and transcription of the positive-sense vRNAs (48). After the synthesis of as little
as one minus strand RNA, the P123 component of the replicase complex is further
processed as nsP1 is cleaved off to generate the short-lived nsP1-P23-nsP4
complex (47, 49). After P23 is processed in trans by another nsP2 protein or nsP2containing polyprotein, the four nsP proteins together form the fully mature
replicase complex that synthesizes both the genomic and subgenomic strand (47,
49-53). This viral RNA synthesis is located in invaginated spherules of the plasma
membrane, however the specific site of the spherules is dependent on the
particular alphaviral species (54, 55). The structural polyprotein is translated from
the subgenomic RNA (sgRNA) strand in the order of Capsid-pE2-6K/TransFrameE1. Like the nonstructural polyprotein, the structural polyprotein is proteolytically
processed into monomeric proteins during infection. After the capsid (CP) protein
is translated, it autoproteolytically cleaves itself off from the other proteins,
inactivating the protease activity in the process, where it is then free to interact with
the genomic RNA (gRNA) to form the nascent nucleocapsid core (51, 56).
Consequentially, the leftover structural polyprotein contains a signal sequence that
targets the remaining translation to the ER for processing where it is then cleaved
by host proteases like signalase and furin proteases, and post-translational
modifications are added to the glycoproteins and TransFrame (TF) protein (57-65).
After being glycosylated, palmitoylated, and the disulfide bonds rearranged, the
glycoproteins are then trafficked and displayed on the host cell surface. Capsid
and E2 then interact which is thought to be a major driver of the budding of the
newly formed virions from the infected host cell (66-68).

5

Figure 1.1 Alphaviral Lifecycle A schematic diagram of the major lifecycle
events as noted in the text.
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Genetic Organization of Alphaviruses
Alphaviruses produce three RNA species during infection that are replicated
or translated: the genomic strand, the minus strand, and the subgenomic strand
as demonstrated by Figure 1.2. In total, the viral genome is about 11.5kb long
which often begins with a type0 7meGpppA cap and ends with a 3’ poly(A) tail (51,
69-71). The Alphavirus genomic RNA has two coding regions, of which only the
first acts as an open-reading frame (ORF), which encodes the nonstructural
proteins that create the viral replicase complex. The second ORF translates from
the sgRNA and contains the coding information for the structural proteins that will
make up the virion. The Minus Strand RNA is made from the full-length gRNA by
the P123-nsP4 polyprotein, and as this RNA is a negative-sense copy of the
genomic RNA it acts as the replication template for the synthesis of the other viral
RNA species (51).
Alphaviruses have several sequences and RNA structures in coding and
non-coding regions that are essential for a productive lifecycle. The 5’ terminus of
the vRNA is implicated in replication, translation, and virulence. First, the type-0
cap on the 5’ end allows for the vRNA to appear and function as a host mRNA,
allowing for immediate translation by the host machinery (51). Both of the 5’
untranslated regions (UTRs) of the gRNA and sgRNA are highly structured, which
is believed to allow for the recruitment of host proteins required for efficient
replication and translation (72, 73). The 5’ UTR and the complementing negative
strand 3’ UTR contain core promoter elements that are critical for plus and minusstrand RNA synthesis. Near the beginning of the coding region of nsP1, the 5’ end
7

also contains a conserved sequence element (CSE) that is important for replication
in mosquitoes but not the mammalian host (74).
The 3’ UTR of the alphaviruses is in general much longer than the 5’ UTR
proper, and it has several key components that are important to lifecycle and
infection. Most alphaviruses have repeated sequence elements (RSE) and a CSE,
with the amount of RSEs varying from 2-5 (75). While there is not a complete
picture of the RSE function, they are thought to be beneficial to replication in
mosquito cells. Deletion of the RSEs reduces replication in mosquito cell lines, and
CHIKV has kept the RSEs through multiple adaptations and evolutions, thus they
are important for the viral lifecycle within mosquito cell lines. Similar RSEs are
noted in closely related viruses, indicating the viruses came from a common
ancestor (76, 77). The CSE is 19 nucleotides long and comes immediately before
the poly (A) tail. It serves as a promoter for negative strand synthesis, and it is
highly conserved in all alphaviruses (75, 78, 79). The 3’ tail end is also important
in host protein interactions, which is discussed in detail later in Chapter 2.

8

5’

3’

3’

5’
5’

3’

Figure 1.2 Alphavirus Genetic Organization Schematic diagrams of the coding
organization of the SINV Genomic (top), Minus (middle), and Subgenomic (bottom)
RNAs. The individual components of the nonstructural and structural polyproteins
are indicated as are the untranslated regions (UTRs) and major features of the
RNAs. Individual components are drawn to scale, relative to one another.

9

Nonstructural Proteins
The nonstructural polyproteins P123 and P1234, the latter of which is made
by a read-through of the Opal stop codon UGA after P123, are essential to viral
replication as they constitute the viral replicase complex (50). As described earlier,
individually or within the polyprotein, the nsP2 protein has the ability to
proteolytically cleave off nsP4 from the polyprotein. The early complex that
synthesizes the minus strand RNA is formed by P123 and nsP4, as nsP4 is the
viral RNA-dependent RNA polymerase (RdRp) (47). This early complex almost
strictly synthesizes the minus strand but is also capable of synthesizing full-length
viral genomic RNAs (48, 80). Shortly after replication complex formation, nsP1 is
cleaved from P123, which marks the termination of minus strand synthesis. The
incredibly short-lived complex nsP1-P23-nsP4 then forms, which can synthesize
both the genomic and subgenomic RNA. Finally, P23 is processed into nsP2 and
nsP3, and it irreversibly forms the late complex consisting of the monomeric forms
of the viral nsPs. Again, the fully mature replicase is responsible for the production
of positive-sense genomic and excessive subgenomic vRNAs (47, 49).

The nsP1 Protein
The viral nsP1 protein primarily functions in three ways: as a
methyltransferase and guanylyltransferase for viral RNA capping, as an anchor for
the replicase complex to the host cell membrane, and the formation of the pore to
the replication spherules. The N-terminal domain contains a Rossmann-like
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methyltransferase fold that transfers the methyl group to form the m 7 Gppp moiety,
and then the guanylyltransferase activity of nsP1 transfers that functional group to
the vRNA, forming the cap structure (81, 82). This enzymatic capping activity is
independent of nsP1’s binding to the cell membrane (83). Initially, the nsP1 protein
weakly binds to the host membrane by way of an amphipathic helix, later in which
cysteine residues within the helix are palmitoylated to strongly anchor the nsP1
protein to the membrane, presumably via the action of one or more palmitoyl
transferases found at the membrane interface, although the mechanism by which
is still unknown. The palmitoylation allows nsP1 to look like a host membrane
protein and integrate into the host membrane in a more permanent fashion (8489). Finally, nsP1’s ability to bind to the cellular membrane allows for the formation
of the replication spherule centers. Twelve copies of nsP1 form a crown-like ring
complex with an inner pore that allows for the transfer of RNA and small proteins
but restricts access of immune sensors from the dsRNA intermediate during
infection (90, 91) The ring formation of nsP1 has a hook-like structure that interacts
with one copy each of nsP2 and nsP4 to form the functional replicase machinery
(92).

The nsP2 Protein
As stated above, nsP2 is integrally involved in the processing of the
nonstructural polyprotein. As well as being a well-defined protease, the nsP2
protein also has helicase and triphosphatase activities during infection. The
protease function of the C-terminal domain is primarily responsible for the
11

processing and cleavage of the nonstructural polyprotein (93, 94). Mutant strains
either lacking the proteolytic activity or with differential timing of cleavage have
decreased replication or ablated infection (47, 95, 96). Via the nsP2 proteins’
helicase activity, the nsP2 protein is heavily involved in RNA replication and
translation as it unwinds the vRNA in coordination with the nsP4 protein (97-100).
In addition to the other enzymatic functions above, the nsP2 protein also has a
triphosphatase motif that is responsible for the removal of the phosphate from the
5’ end to become a diphosphate, which prepares the RNA as a substrate for
capping by nsP1 (96).
An additional critical function of the nsP2 proteins of OW alphaviruses is
their capacity to restrict host transcription. Replicons strictly encoding the nsPs
exhibit the same transcriptional shutoff ability as wild-type (WT) virus infection, and
several studies with nsP mutants have shown that nsP2 is responsible for the
shutoff in OW viruses but not NW viruses (101). This has been specifically shown
using a SINV mutant that has a single point mutation in the nsP2 protein, P726G,
which is deficient in regard to host cell transcriptional shutoff (102). This key
feature is important to infection, as this mutated virus induces decreased cell death
and exhibits diminished viral growth in cell culture. The OW nsP2 protein can
translocate to the nucleus and degrade RPB1, a subunit of the DNA-dependent
RNA polymerase II (103). This degradation shuts down host transcription and
inhibits the host’s innate anti-viral response. The role of transcriptional shutoff is
transferred to the capsid protein in New World alphaviruses and is discussed later
in this chapter (104).
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The nsP3 Protein
While the other alphaviral nsPs have been thoroughly characterized, the
function of nsP3 has for many years been evasive and perplexing to the field. The
protein is comprised of three domains: the N-terminal macro domain, an Alphavirus
Unique Domain (AUD), and the C-terminal Hyper Variable Domain (HVD). The
conserved alphaviral macrodomain has both the ability to bind to nucleic acids and
exhibits phosphatase capabilities, which could be involved in host protein
interactions (105). As well as these functions, the nsP3 macrodomain has a dADP-ribosylation activity that counteracts the anti-viral ADP-ribosylation response
(106-108). As such, targeting the ribosylase activity has been proposed as a
therapeutic strategy. Next in the nsP3, the AUD is strongly conserved among the
alphaviruses, and mutations in this area cause inhibition of RNA synthesis,
polyprotein processing, as well as neurovirulence (109-111). Finally, the HVD is
exactly that: highly varied across the 30 different alphaviral species (112). While
there are some conserved elements in the HVD, like being highly phosphorylated,
the comparison of the lack of a consensus allows researchers to determine the
function of the HVD by identifying cryptic conserved motifs within the HVD (87,
113, 114). Interestingly, the phosphorylation state of the VEEV HVD is important
for replication in mosquito cells, but not in vertebrate cells; and mainly, the HVD
seems to be a hub for host protein interactions, which are discussed in thorough
detail in Chapter 2 (115).
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The nsP4 Protein
The final nonstructural protein is the viral RNA dependent RNA polymerase
that is responsible for RNA synthesis, as well as formation of the poly(A) tail of the
genomic and subgenomic RNA. Due to its molecular nature and function, the nsP4
protein is the most conserved nsP, which strongly resembles all other known RNAdependent RNA polymerases (116, 117). The N-terminal domain is unique to
alphaviruses, and the C-terminal end has the polymerase activity that is similar to
other viruses. In addition, nsp4 has adenylyltransferase activity that is responsible
for the polyadenylation of the 3’ tail end of the virus (80, 118, 119). The high
mutation rate of alphaviruses and formation of a quasispecies is due to the lack of
any discernable proof-reading capability of the RdRp. Stoichiometrically, there is
less nsP4 protein made relative to the other nsPs, as there is a leaky Opal stop
codon at the end of nsP3 although not all alphaviruses, like SFV, have the stop
codon (50, 51, 109). This will occasionally stop translation before the machinery
travels to the nsP4 region for. Studies mutating this codon and forcing readthrough
increases the ratio of nsP4 to the polyprotein P123, which increases RNA
synthesis (120). However, this has an overall negative effect on infection and
causes attenuated disease in mouse models, thus the ratio of nsP4 to P123 plays
an important role in severe infection.
Architecturally, nsP4 is located in the center of the membrane pore of the
viral replicase complex, as the nsP1 ring tightly holds the protein there by flexible
loops. This orients nsP4 to where the RNA entry and exit pockets are facing the
14

spherule side and the NTP entry is located on the cytoplasmic side. The interaction
between nsP1 and nsP4 forms a disk that nsP2 then docks onto and hooks onto
the flexible loops of nsP1, which also increases stability for the active conformation
of nsP4 (92).

Structural Proteins
The translation of structural proteins is very similar to the nonstructural
proteins, although the structural proteins come from the ORF of the 26S
subgenomic strand. In SINV, there are approximately three times the amount of
subgenomic RNA strands as there are full genomic RNA strands, which is partly
responsible for the immense production of the viral structural proteins relative to
the viral replication machinery. The result of translating the subgenomic RNA
strand is a polyprotein precursor of the structural proteins including capsid, the pE2
glycoprotein predecessor (which consists of E3 and E2), the 6K / transframe (TF)
proteins, and the E1 glycoprotein (121). All together and in concert with one
another, these structural proteins make up the mature infectious virion. In totality,
the alphaviral virion is made up of one genomic vRNA molecule surrounded by a
nucleocapsid core composed of the capsid protein(122, 123). This nucleocapsid
core is safely packaged in an envelope consisting of the host lipid bilayer in which
240 copies of the E1 and E2 heterodimer are inserted (124-126). The glycoproteins
form an icosahedral lattice with a T=4 symmetry in alignment with the underlying
capsid proteins of the nucleocapsid core (127). This co-symmetry is oddly unique
to alphaviruses, and not observed in any other known enveloped virus.
15

Capsid
Capsid is the first protein translated in the structural polyprotein, and it
autoproteolytically cleaves itself off the polyprotein immediately after synthesis
(128, 129). Capsid has two domains: the N-terminal domain which has little
structure or conservation besides being highly positively charged and proline-rich,
and the C-terminal chymotrypsin-like serine protease. Despite having little overall
conservation, the N-terminal domain of the capsid protein has several distinct
subdomains / features. The first distinct region of the N-terminal domain is an alpha
helix that is involved in the dimerization of the capsid protein (130). The second
region is smaller and is involved with the recognition of the RNA packaging signal
and the disassembly of the nucleocapsid core during entry (131, 132). The
protease function of the C-terminal end only exists for the cleavage of capsid from
the structural polyprotein as, to date, no other targets have been identified (133,
134).
Interestingly and importantly, capsid is able to selectively determine and
package the genomic vRNA into the nucleocapsid core over sgRNA and cellular
RNAs, and it has been shown that deletions or mutations of the protein can cause
it to package other RNAs indicating it has high specificity for gRNA (135-137).
Unfortunately, the mechanism behind nucleocapsid assembly and gRNA
packaging is not fully understood.
In the New World Alphaviruses, capsid is involved in host translational
shutoff rather than nsP2 as is known for the OW alphaviruses. In a study conducted
by Atasheva et al, VEEV capsid regulates nucleocytoplasmic trafficking by
16

blocking nuclear import pathways effectively stopping host transcription and
translation (138). The loss of the nuclear localization signal and the nuclear export
signal in capsid allowed nuclear trafficking. Some OW alphaviruses such as CHIKV
also have a nuclear export signal and interact with the nuclear export protein CRM1, however abolishing this interaction did not have as detrimental as an effect as
the New World viruses (139).

TF/6K
The 6K and the alternatively produced TransFrame (TF) proteins are less
understood than the other proteins of the structural polyprotein. They are
translated from the same coding frame, and 6K is the predominant product of the
polyprotein, however, in a minority of times, there is a frameshift upstream of the
E1 coding sequence and a stem loop structure that causes TF to be made (58).
Although the exact frequency is unknown, and certainly varies amongst the
individual alphavirus species, frameshifting is estimated to occur about 30% of the
time. As the synthesis of TF precludes the synthesis of the E1 glycoprotein the
stoichiometric ratio of E1 and E2 is not the same, however, the precise
consequences of differential amounts of the glycoproteins being produced is not
well understood (57, 58, 62, 140). It is no accident that TF is made, as the
production of TF is conserved across alphaviruses and TF, but not 6K, seems to
be mostly packaged in the released virion (57, 62, 141). 6K/TF are required during
animal infections but seem to be dispensable in cell culture models (142, 143). The
roles of these proteins have not yet been extensively defined, but 6K has been
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proposed to act as a viroporin; whereas TF is a virulence factor involved in
inhibiting interferon (IFN) synthesis, and the palmitoylation of TF is important for
particle assembly (144-146). TF palmitoylation is necessary for localization to the
plasma membrane which could ‘hide’ the virus away from vRNA sensors, or it has
been proposed that it can interact with host proteins that sense vRNA.

Glycoproteins
The glycoprotein spikes are made up of 240 copies of E1 and E2, in which
E2 is the attachment protein that binds to the host cell receptor, and E1 is a class
II fusion protein that mediates membrane fusion (147). Both glycoproteins are
critically important for virulence, replication, and dissemination.
After capsid is translated and cleaved, the remaining polyprotein consisting
of pE2( the fused form of the E3 and E2 glycoproteins), 6K/TF, and E1 is then
translated and relocated to the ER membranes due to an internal signal sequence
located in the E3 protein (148, 149). Alphaviruses utilize host proteases to cleave
the structural polyprotein into E3, E2, 6K (or TF), and E1. As the proteins are
trafficked through the secretory pathway, pE2 and E1 form a heterodimer, and
because E3 has not yet been cleaved off, it acts as a chaperone to promote proper
folding of the spike complex (150-152). During this time, the glycoproteins undergo
several post-translational modifications which are discussed in detail later (60,
153-156). For E1 and E2 to form the fully mature heterodimer, pE2 must be
cleaved by a host furin protease, and E1 then goes through disulfide bond

18

rearrangements to form the quasi-stable prefusion structure (153, 154, 157). To
finish the alphaviral lifecycle and for virions to bud from the cell, capsid and the E2
glycoproteins must interact. This interaction is mediated by the endodomain of E2
extends into capsid’s hydrophobic cleft within its protease domain, and then loops
back to form a hairpin-like turn with the C-terminal end palmitoylated and anchored
to the cell plasma membrane (158, 159). This interaction starts the budding and
final step of the alphaviral lifecycle, although the exact mechanism behind this is
yet to be elucidated.

Structural Protein Processing
After the self-cleavage of capsid from the structural polyprotein and the
targeting to the ER membrane, the structural proteins then must be processed
before they are fully functional. These processes are carried out by the host and
are critical to trafficking through the ER pathway as well as arraying the
glycoproteins correctly to form the final virion. The first polyprotein and final
glycoprotein forms are illustrated by Figure 1.3.

Disulfide Bond Formation
There are several cysteines in the E1 glycoprotein that go through disulfide
bond arrangement to allow for the proper folding of the glycoproteins (154, 160).
This is a critical step during the glycoprotein spike formation. E1 can have three
different disulfide bond configurations, with the final configuration being the most
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compact and most stable. The disulfide bond between E1-E1 interactions is what
forms the rigid protein lattice of the virion. Several host molecular chaperones
promote disulfide bond formation and proper folding of the glycoproteins, including
BiP which binds to E1, and the Cnx/Crt pathway for pE2 (160).

Glycosylation of the Glycoproteins
The alphaviral glycoproteins are N-linked glycosylated, and the sites of
these in E1 and E2 are conserved across the alphaviruses. Glycosylation of these
proteins is important to function in various ways, including proper folding and
increasing structural diversity and therefore altering recognition by the host
immune system (161, 162). Many glycosylation mutants have impaired viral
replication and infectivity, however interestingly enough a mutation in the SINV E2
region decreasing glycosylation caused increased replication and virulence in mice
(162, 163). This was due to the lack of glycosylation causing increased binding
efficiency to heparin sulfate, which allowed for better entry into cells. N-linked
glycosylation of E1 and E2 are important for conformation of the glycoprotein spike,
as mutating the glycosylation sites effect the ability to form functional spikes that
can fuse to the host cell (164). Since the E2 glycoprotein is prominently displayed
on the glycoprotein spike, it is mainly involved in the attachment of the host
receptor. Studies inserting or deleting glycosylation sites on the glycoprotein show
that glycosylation can affect viral attachment, viral assembly, and antibody
reactivity, all which have an effect on neurovirulence in the host.
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Palmitoylation of the Glycoproteins
There are several structural proteins that are palmitoylated, including E1,
E2, and TF but not 6K. SINV cysteine residues are palmitoylated at position 430
in E1 and positions 388 and 390 in E2 (59-61). The mutation of the palmitoylation
sites caused a decrease in viral growth, and the mutant viral particles were more
susceptible to detergent treatment. It was also observed that palmitoylation is
dispensable for the viral fusion to the plasma membrane, however no further
characterization of the function of palmitoylated glycoproteins has been done. The
first evidence of TF being palmitoylated was originally thought to be 6K with two
different modification statuses, as the study used an antibody directed to the
shared sequence of TF and 6K (165, 166). Follow-up studies found that TF, but
not 6K, was always palmitoylated during infection. TF palmitoylation is critical for
trafficking, however the exact mechanism is not known (62).
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Figure 1.3 Structural Processing of the Viral Glycoproteins A schematic
cartoon of structural polyprotein processing during SINV infection in the ER and
the Golgi after cleavage of the Capsid protein. Indicated above are the sites of host
protease cleavage as needed for glycoprotein maturation. Also shown are sites of
glycosylation and palmitoylation, as indicated by hexagons and squiggles,
respectively.

22

Necessity of Host Factors in Alphaviral Infection
Alphaviruses are positive sense, single-stranded RNA viruses that are
incredibly dependent on the host to complete the full alphaviral lifecycle
successfully. There are host factors interactions with the nonstructural proteins that
help promote viral replication and translation, as well as interactions that are critical
to shut down the host system to make cells into viral factories (167-169).
Alphaviruses also rely on host processes and proteases to process the structural
proteins to form an infective virion (62, 64, 65, 153, 157, 161). Studies that
characterize host protein interactions also help elucidate viral protein functions, as
seen with studies of the nsP3 protein (169, 170). Overall, host protein interactions
with alphaviruses are critical for infection.
How host proteins were discovered to be involved in alphaviral infection and
their role during infection will be discussed in detail in chapter 2.

23

CHAPTER 2
A REVIEW OF HOST RNA BINDING PROTEINS AND ALPHAVIRAL
INTERACTIONS

Introduction
Like most RNA viruses, alphaviruses rely on host proteins and machinery to
translate vRNA and package the virion to complete the viral life cycle. For over 30
years, there have been many studies conducted with the goal of determining what
host proteins interact with alphaviruses during infection. Though these studies all
look at host protein interactions through different methods, host RNA binding
proteins (RBPs) have consistently emerged as an interactant. As such, it is
important to comprehensively examine the discovery efforts of host RNA binding
proteins interacting with alphaviruses to illuminate the importance of RBPs to
alphaviral infections.

Discovery Efforts
Protein: Protein Interactions
Since studies from the Strauss lab first identified host proteins that bound to
the vRNA to influence viral RNA biology during infection, efforts expanded to
understand the full repertoire of host factors required for alphaviral infection (171).
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In the early days of molecular host / pathogen screens for alphaviruses,
comprehensive discovery efforts focused mainly on Protein:Protein interactions
due to the available technology at the time. Over a series of likewise efforts
reported by the Frolova / Frolov group and the MacDonald group, the authors
collectively probed nsP3 interactions to identify interacting host factors (169, 170).
Both groups employed an approach involving SINV strains containing a green
fluorescent protein (GFP) in the nsP3 ORF to enable the purification of
Protein:Protein complexes. In Frolova et al. 2006, the authors infected BHK-21
cells using recombinant nsP3-GFP strains of SINV, and 8 hours post infection cell
lysates were fractionated and immunoprecipitated with anti-nsP3 or anti-GFP
antibodies. Electrophoretic analysis via SDS-PAGE was then used to resolve the
interactants of nsP3, which led to the excision and identification of about 30
proteins by matrix-assisted laser desorption / ionization-time of flight (MALDI-TOF)
mass spectrometry (MS) (169). Later work by Cristea et al. 2006, similarly utilized
nsP3-GFP fusion proteins to evaluate the host / pathogen protein interactions
during infections with respect to time. However, this approach differed in that the
authors added an additional SINV virus strain, with a freely expressed GFP behind
a secondary subgenomic promoter. This allowed the authors to answer the
question as to whether a host protein interaction with nsP3 was a true interaction
with the viral protein, or whether proteomic changes due to viral infection and the
addition of GFP were responsible for the interaction. Briefly, 293HEK or RAT2 cells
were infected with a SINV reporter virus containing GFP fused to the nsP3 protein.
At several times post infection, following rapid freezing and cryogenic lysate
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preparation to preserve biologically relevant complexes the nsP3-GFP complexes
were isolated via immunoprecipitation. The resulting materials were assessed
using standard SDS-PAGE analyses and MALDI mass spectrometry. The efforts
reported in Cristea et al. 2006 led to the identification of around 35 host factors of
which 10 of those were previously found by the Frolova group (170).
Both of these studies elucidated several host RNA binding proteins that interact
with nsP3 during infection; including G3BP1&2, hnRNP A3, hnRNP A1, and 14-33 epsilon, zeta, and eta. In Frolova et al., the authors go on to characterize the
biological significance of interacting proteins hsc70 and vimentin by visualizing
colocalization. Hsc70 relocated from the nucleus to colocalize with nsP3 in the
cytoplasm, however no specific biological significance was determined for vimentin
(169). This could be due to vimentin being an artifact of a nonspecific interaction
during viral infection as this protein was also found in the control group of the study
done by Cristea et al. 2006. As stated above, Cristea et al. 2006 found that host
G3PB proteins were consistently involved with the viral nsP3 throughout infection,
while co-localizations of the other RBPs during infection were temporally
dependent, with the 14-3-3 adapter proteins interacting with nsP3 protein late
during infection. Importantly, the authors characterized the nsP3 interaction with
the G3BP proteins and determined that the NTF2-domain of G3BP1 interacts with
the viral nsP3 and reduces the interaction between G3BP and nuclear pore
proteins. While G3BP is normally involved in stress granule formation, this
subversion of the protein during infection provides another role, one that which
G3BP promotes nonstructural polyprotein processing and viral replication (170).
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While alphaviral nsP3 Protein:Protein (P:P) interactions have been extensively
described, there have been relatively fewer studies designed to directly assess the
P:P interactions of the nsP2 protein. Work by Svetlana Atasheva in the Frolova
group identified host / pathogen interactions using an nsP2-GFP fusion protein
during SINV infection and SINV replicon system transfections of BHK-21 cells
(172). As before with nsP3, nsP2-GFP complexes were immunoprecipitated and
several host factors were isolated using SDS-PAGE for identification by MALDITOF analysis. Quite a few of these host proteins were identified in the previous
publication identifying nsP3 interactants, suggesting that these identified host
proteins could be interacting with the whole replicase complex. This has been
confirmed by Varjak et al, as they isolated functional replicase complexes and
found some of the same host proteins, as discussed later in this section (173).
Moreover, several host RNA binding proteins were specifically associated with
nsP2, namely hnRNP C and PABP.
Host / pathogen P:P interactions of the RNA-dependent RNA polymerase nsP4
have been furthered characterized by the MacDonald group, as described by
Cristea et al. 2010. At first, the group continued parallel efforts to their previous
publication by using a GFP-nsP4 fusion protein; however, attempts using this
approach were unsuccessful as that virus was nonviable (174). To overcome this
challenge, they generated a FLAG-tagged nsP4 fusion virus as it was a smaller
epitope for antibody capture. Isolation and immunoprecipitation of the complexes
led to the identification of 29 distinct host protein interactions in infections of Rat2
orBHK-21 cells. Importantly, they found several common interactants found in the
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nsP2 studies done by the lab, including G3BP1&2 and 14-3-3 adaptor proteins. To
further the understanding of functional roles G3BPs may have, Cristea et al
silenced G3BP1 and G3BP2 and found that it slightly enhanced SINV polyprotein
expression and viral production (174).
The majority of host protein / pathogen interactions have been determined in
cellular systems using the model alphavirus, SINV, however it was not known at
the time if these interactions were transferable to other similar old-world
alphaviruses. In a study done by Bourai et al, it was found that there were mostly
conserved, with some distinct, interactions with CHIKV nsP2 (175). This group
used a high throughput yeast two-hybrid assay and found 22 host protein
interactions with the viral nsP2. Additionally, the authors confirmed CHIKV nsP2
contributed to host transcriptional shut-off, similar to other old-world alphaviruses.
To characterize specific host protein interactions during CHIKV infection, Bourai et
al. used siRNA to knockdown host proteins, specifically hnRNP K and UBQLN4,
and then determined CHIKV replication by luciferase activity. Knocking down these
proteins caused decreased viral replication and reduced viral titer, and infection of
HeLa cells produced colocalization with CHIKV nsP2 (175).

RNA: Protein Interactions
It is a common premise of old-world alphaviruses to subvert host proteins
during infection, specifically RNA binding proteins, however the majority of the
beginning studies only looked at P:P interactions. Furthermore, as Varjak et al
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pointed out, many interactions with host proteins could have been missed by P:P
capture methods since interactions could be transient, or interact with the vRNA
and not the viral replicase machinery (173). While the structure of the replicase
complex has been recently discovered, it is still unknown where host proteins fit
into this structure as they were not resolved in the Cryo-EM reconstructions. During
this time there was a larger shift of focus away from P:P interactions to the vRNAs
themselves. To this end, Varkjak et al isolated functional replicase complexes via
magnetic fractionization and found many hnRNPs that interacted with the SFV
RNA and the replicase complex, some of which had been found to interact with the
separate proteins of the replicase complex in previous studies. Specifically, they
further discussed the colocalization of PCBP1, hnRNP M, hnRNP C, and hnRNP
K with SFV, and the effect of silencing on multiple different alphaviruses infection.
Interestingly, silencing these proteins caused different effects on infection;
however, whether these effects are attributable to silencing host RNA binding
proteins with known roles in normal cellular function, or a specific loss of the host
factor on alphaviral infection is not distinguishable with this approach (173).
While host / alphaviral interactions have been extensively studied, until recently
there have been relatively few findings, and fewer comprehensive discovery
studies examining the direct interactions of host proteins and the alphaviral RNAs.
Even so, the field at large is focusing on direct RNA interactions due to the newly
developed methods. As such, LaPointe et al studied the direct RNA interactions of
host proteins by using a cross-link-assisted mRNA purification (CLAMP) assay to
determine what host factors were interacting with the alphaviral RNA and
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confirmed three hnRNP (K, I, and M) interactions via UV cross-linking and
immunoprecipitation sequencing (CLIP-seq) (176). To characterize these
interactions, the authors implemented a reverse genetics approach and made
silent mutations in the mapped interaction sites. This disrupted hnRNP:vRNA
binding, reduced viral titer, and intriguingly increased structural gene expression.
This work was also later expanded by Gebhart et al, as the authors studied
common interactants of the vRNA of SINV, CHIKV, and VEEV (177). They found
108 common host proteins that interact with the vRNA of the three different
alphaviruses. After coimmunoprecipitating the vRNA from three different protein
interactions, hnRNP K, hnRNP A1, and ANP32A, they found that even though
these viruses share the protein interactions, they might do so at different affinities.
To date, RBPs have proved essential to alphavirus infection. Most studies
have focused on host / pathogen interactions from the viral side as in what host
proteins are interacting with alphaviruses. Work done in the Castello lab have tried
to identify system wide changes in RBPs due to SINV infection (178). To this end,
the study done by Garcia-Moreno, Noerenberg, Ni et al. used a method called
RNA-interactome capture to determine what RBPs were important during SINV
infection compared to non-infected cells. This method uses a mixture of isotype
labeling during infection and then crosslinks the interactions by UV. After cell lysis
and oligo(dT) capture, the samples were quantified by proteomic analysis. Using
UV crosslinking identifies more specific interactions that happen in large quantities,
however it misses interactions that are transient or have small amounts of cellular
proteins. Despite this, the authors found that there are around 250 total RBPs that
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have ‘differential’ binding during SINV infection. While the authors did find novel
RBP interactions through this approach, they did not identify several previously
found RBPs that have emerged during numerous studies (178). For instance, this
approach failed to detect hnRNPA1 in viral replication areas, which has been very
well established by the Li group, however the authors attribute this to the EGFP
tag effecting protein localization (179). Garcia-Moreno et. al, go on to describe how
XRN1 is important for SINV to replicate, and GEMIN5 regulates capsid protein
expression (178).
Even as new approaches are developed and the field has moved away from
Protein:Protein interactions, the characterization of RNA:Protein interactions is
relatively new for the field. As such, there has been some limited descriptions and
attributions of functions of RBPs during alphaviral infections, of which the known
and unknowns are extensively discussed in the next section.
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Host Factor
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(RepC), or vRNA.

Protein Name UnitProt ID nsP1 nsP2 nsP3 nsP4 RepC vRNA

BCLAF1
CHTOP
CSTF2
CSTF2T
DDX1
DDX10
DDX17
DDX18
DDX24
DDX31
DDX3X
DDX5
DDX50
DDX52
DDX54
DDX56
DHX9
DKC1
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FXR1
G3BP1
G3BP2
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GEMIN5
HABP4
hnRNP A0
hnRNP A1
hnRNP A2B1
hnRNP A3
hnRNP C
hnRNP G
hnRNP H1
hnRNP K
hnRNP M
hnRNP R
hnRNP U
HNRNP AB

Table 2.1 RBP Interactions with Alphavirus Table of mammalian RBPs and

indicated interactions with alphaviral nonstructural proteins, replicase complex

Specific Roles of RBPs During Alphavirus Infection
While discovery efforts to determine the host proteins involved in alphaviral
infection are important (Table 2.1), it is also vital to determine the function of these
host protein interactions to viral infection. Thus, the second goal of this chapter is
to explain in depth the studies performed to characterize these interactions.
1. La- A Possible Replication Regulator of 3’ Minus Strand:
In the early 1990’s, efforts from the Strauss lab identified which
cellular proteins interacted with SINV RNAs, and found that several host
factors bound to the 3’ end of the Minus Strand RNA of SINV. As reported
in later work by Pardigon et al., one of these host proteins were determined
to be the cellular La protein. La was hypothesized to be important for SINV
RNA replication as it normally binds to the 3’ end of host transcripts and
regulates transcription; however, unfortunately further studies could not be
concluded due to high intracellular concentrations preventing complete
silencing / knockdown and the La protein’s essential role during
embryogenesis. Thus, despite being the first recorded instance of a host
RBP affecting viral RNA function, much is still unknown regarding the
importance of La to infection (168, 171).

2. HuR / ELAV1–- Stabilizing the Alphaviral RNAs from 3’ RNA Decay:
The HuR / ELAV1 proteins, and its closely related homologs with
tissue specific expression patterns, are RNA recognition motif (RRM)
containing proteins that have been identified as potent regulators of RNA
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stability and gene expression (180, 181). RNA stability conferred by HuR is
imparted by direct interactions of the HuR protein with poly(U)-rich (URE)
and AU-rich elements (AREs) found in the 3’UTRs of cellular transcripts
(181-184).
Using a series of tissue culture model systems and biochemical
approaches it was found that the host protein HuR not only binds to 3’ UTR
and AU-rich regions of cellular mRNAs and stabilizes them, but also binds
to the 3’ UTR of alphaviruses to stabilize them for successful infection (185).
The HuR protein is conserved in both mosquitoes and humans, and both
homologs have been found to associate with similar elements in the
alphaviral 3’UTRs (186). This conservation implies that HuR binding could
be important for infections across multiple host systems. During infection,
HuR will bind to either the RSE, the URE and/or the CSE depending on the
alphavirus and prevent deadenylation to keep alphaviral mRNAs from being
degraded (187). While HuR is located in the cytoplasm in mosquito cells, it
is located in the nucleus in mammalian cells and relocates to the cytoplasm
after dephosphorylation during SINV infection (188). Relocalization of the
HuR protein is not due to cellular stress, but is a response specifically found
in alphaviral infections as infection with Measles or Dengue viruses did not
cause relocalization (188). Knockdown of HuR or the deletion of the binding
site in the SINV 3’UTR caused reduced viral titer in both mammalian and
mosquito tissue culture models. While HuR binds to the URE region of
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SINV, the CSE region is needed for binding of RRV and CHIKV as well as
the third RSE for CHIKV.

3. G3BP1/2- Regulation of Alphaviral Replicase and Minus Strand Synthesis:
Ras GTPase-activating protein-binding protein 1 and 2 (G3BP1/2)
are critical for the formation and activation of stress granules due to multiple
different environmental stressors, including viral infection (189-191). These
proteins form homo- and hetero-multimers with each other to induce stress
granule formation (192).
G3BP1 and G3BP2 are homologous and have some redundancy in
alphaviral infection so in most studies they are collectively referred to and
studied as G3BP. Studies involving the role of the G3BP protein during
alphaviral infection have been a prolific area of study, and as such the
G3BPs have been found to interact with the nsP3 proteins of around 17
different alphaviruses, and also replicase proteins nsP2 and nsP4 (170,
172, 174). Studies performed by Cristea et al in the MacDonald lab found
that the knockdown of G3BP caused viral nonstructural protein expression
and titer to be significantly increased starting early in infection and kept the
trend through late infection(174). However, knockdown only slightly effected
RNA levels, but not enough to attribute the change in titer. The mosquito
homologue of G3BP is Rasputin (Rin), and knockdown of Rin also did not
significantly affect CHIKV RNA levels during infection (193). To determine
at what point G3BP is affecting the viral lifecycle, Scholte et al determined
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that G3BP was not linked to CHIKV entry or nonstructural protein translation
but was involved the switch to negative strand synthesis (194). The
McInerney lab comprehensively studied the effect of G3BP knockdown on
several alphaviral nsP3s interactions and found that for most old-world
alphaviruses replication and transcription were reduced (195). Further
characterizing this interaction, the authors found a link between
nonstructural polyprotein processing and G3BP dependence. Overall, they
concluded that G3BP is proviral at several points through the alphaviral
lifecycle, as it most likely is involved in activation of the replicase and
negative strand synthesis, but not the switch from RNA translation to
replication (195, 196). Despite G3BP’s role in binding to the alphaviral
replicase complex being a subject of extensive investigation, the role of
G3BP specifically as an RBP is largely overlooked. While G3BP may be
involved in RNA replication and minus strand synthesis, it is intimately
linked to the replicase as a complex. At this point with current technology, it
would be nearly impossible to distinguish the impact of G3BP on RNA
binding without disrupting the viral replicase.

4. TIA1/R- Promotes Infection by Forming Stress Granule Decoy:
T-cell-restricted intracellular antigen 1 (TIA1) and TIA1-Related
protein (TIAR) proteins regulate protein translation, RNA splicing, and
stress granule formation (197-199). These proteins are included into
initiation complexes, which then collect and sequester these initiation
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components away in SGs in response to environmental or intracellular
stress stimuli. During alphaviral infection, SGs are disassembled in the
vicinity of viral replication complexes despite viral infection inducing a clear
state of cellular stress (200). McInerney et al explored the importance of
these proteins during SFV infection and found that TIA1/R diffused away
from SGs throughout the cell when viral replication was active. In TIA1
knockdown MEF cell lines host cell translational shutoff was delayed, and
early SG formation was decreased. This led the authors to conclude that
TIA1/R forming SGs at the beginning of viral infection was fulfilling a proviral role, as it removes cellular mRNAs so the subgenomic vRNAs do not
have to compete for translation with the active polysomes (200). Although
TIA1/R have RNA binding abilities and are involved in RNA splicing, RNA
binding roles on alphaviral RNAs have not been evaluated.

5. GEMIN5- Regulation of Protein Expression Through 5’ UTR Interaction:
Gem-associated protein 5 (GEMIN5) is an RBP that catalyzes the
formation of the spliceosome, can bind to the 7-methylguanosine cap of
RNA strands, and may can control protein synthesis by interacting with the
ribosome (201-203). Garcia-Moreno et al found that GEMIN5 was
significantly stimulated by SINV infection and over-expressing a GEMIN5EGFP fused protein caused a delay in viral subgenomic gene expression
and inhibited capsid expression (178). While GEMIN5 binds to the 3’ UTR
of some host mRNAs, this RBP was found to interact with the 5’ ends of
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both of the SINV RNA species. GEMIN5 effects viral protein expression
through this interaction at the 5’ end, however GEMIN5’s role as an RBP
has not been characterized in depth.

6. FXR1- Interaction with the nsP3 HVD Promotes Infection:
The Fragile X-Related Protein 1 (FXR1) is involved in posttranscriptional mRNA regulation (204). After discovering FXR1 that
interacts with SINV nsP3, the Frolova/Frolov group continued to functionally
characterize this interaction (169). The Protein:Protein interaction of FXR1
mapped specifically to the VEEV nsP3 HVD, and FXR1 moves from the
nucleus to the viral replicase complexes during infection (205). Knockout of
the FXR1 family only reduced VEEV viral growth titers while unaffecting the
Old-World alphaviruses SINV and CHIKV. Addition of these proteins
reinstated viral titer almost back to WT like levels, which indicates that the
FXR1 family is important for VEEV infection. Removal of the interaction site
of FXR1 in the HVD region of nsP3 causes diminished pathogenesis of
VEEV and EEEV (206, 207). Further elucidating this interaction, the authors
found that FXR1 is important RNA synthesis and replicase complex
formation. This interaction also holds true for EEEV, albeit the interaction is
a separate distinct site. Direct impact of FXR1 as an RBP has not been well
characterized in alphaviral infections.
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7. DEAD-box helicases- Promotion of Spreading Infection to Neighboring
Cells:
The family of dExD/H-box RNA helicases are involved in many RNA
processing roles like splicing, transcription, RNA export, translation, stress
granule formation, and innate immune sensing (208-210). As such, many
of these helicases have been isolated during alphavirus interaction studies
as shown in Table 2.1. In studies performed by Amaya et al, they found that
DDX1 and DDX3 interacted with VEEV nsP3 (211). The removal of DDX3
and DDX1 by siRNA knockdown reduced viral titer, intracellular and
extracellular viral RNA. It is interesting that the decrease of intracellular viral
RNA seemed to be more significant at earlier time points in the infection
whereas extracellular viral RNA had a more considerable decrease at
24hpi. This observation was not as evident in the double DDX1/DDX3
knockdown however the same trend of decreased viral titer and RNA levels
late during infection was evident. From this data, the authors conclude that
the role of these helicases are important during multiple rounds of infection,
due to the low amount of virus inoculated and the decreasing trend
becoming more significant at later times during infection (211).
RNA helicase DHX9 is known to unwind DNA and RNA structures
and has been implicated during many other viral infections including
picornaviruses,

orthomyxoviruses,

pestiviruses,

flaviviruses,

and

retroviruses (212-215). Studies completed by Varjak et al and Matkovic et
al both show that DHX9 interacts with the SFV and CHIKV replicase
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complex, respectively (173, 216). Matkovic et al go on to show that DHX9
relocates to viral replicase complexes during infection, and knockdown of
this helicase promotes infection while overexpression of DHX9 inhibits it
(216). DHX9 also negatively regulates both positive and negative RNA
strand synthesis. Since DHX9 can sense dsRNA, it was hypothesized that
DHX9 is involved in innate immune sensing and establishment of an antiviral state. However, IFNβ levels were not affected during knockdown of
DHX9 by CRISPR/Cas9 editing. Interestingly, knockdown reduced genome
translation while overexpression enhanced translation of the viral nsPs
(216). Enhancement of translation but overall reduction in infection with the
lack of DHX9 points to this protein having a role during alphaviral infection,
however an RBP role has not been characterized.

Heterogenous Nuclear RibonucleoProteins (hnRNPs)
Many individual proteins make up this family of RBPs, and they are
all heavily involved in RNA regulation. Individually and altogether, they have
roles that include splicing, mRNA stability, translational and transcriptional
regulation, and mRNA decay (217). The majority of the hnRNPs are located
in the nucleus due to the presence of nuclear localization signals; however,
they can shuttle to the cytoplasm for various reasons during their normal life
as cellular RBPs. Some hnRNPs can also be post-translationally modified
which in turn changes their binding preferences, functions or locations.
There are many hnRNPs that are implicated not only in alphaviral infection
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but many other viral infections as well. The remainder of this chapter will
discuss the hnRNPs involved in alphaviral infection in detail.

hnRNP A1- Promotion of RNA Replication and Synthesis:
This protein is in the hnRNP A/B subfamily, and not only did hnRNP
A1 show up in the majority of the alphaviral interaction discovery efforts, but
it also has been shown to promote infection of viruses such as mouse
hepatitis virus, hepatitis C virus (HCV), dengue virus, human papilloma virus
16 (HPV), and vesicular stomatitis virus (218-222). Studies performed by
Lin et al have concluded that hnRNP A1 relocates from the nucleus to the
cytoplasm during infection where it interacts specifically with the 5’ UTR of
the SINV genomic RNA (179). The knockdown of hnRNP A1 by siRNA
reduced viral gene expression, vRNA synthesis, and viral titer to a
significant extent. Continued work out of Mei-Ling Li’s lab determined that
hnRNP A1 interacts with both the genomic and subgenomic promoters of
SINV positive strand (223). Gui et al went on to suggest that the removal of
this protein from host cells reduces genomic and subgenomic RNA
synthesis, and the addition of hnRNP A1 in knockout cells can rescue the
vRNA synthesis.
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hnRNP C- Negative Regulator of Alphaviral Infection:
Regulatory molecular switches like m6A help hnRNP C bind to the
mRNA and regulate splicing events and mRNA stability during normal host
biology (224). Efforts undertaken by Varjak et al characterized the impact
of hnRNP C on alphaviral infection (173). During hnRNP C knockdown, viral
genomic and subgenomic protein expression was increased as compared
to control cells infected with SFV, CHIKV, and SINV. In addition to hnRNP
C’s effects on translation, viral titer and both vRNA synthesis were
increased as well. Altogether, it is interesting that removal of hnRNP C
allowed for better alphaviral infection, when during normal biology it is
involved in cellular mRNA stability. Thus, for alphaviruses at least, hnRNP
C expression negatively influences viral infection (173). Along a similar vein,
hnRNP C is also implicated in other viral infections, where it seems to have
mixed uses, as like during alphaviral infection, the knockdown of hnRNP C
increased adenoviral protein expression and viral titer; however during
Dengue virus infection, removal of hnRNP C was detrimental to viral
replication and protein expression (225, 226).

hnRNP K- Phosphorylated Form Regulates RNA Synthesis and Gene
Translation:
The hnRNP K protein has three KH domains, which allows this
protein to not only be involved with RNA regulation and processing, but also
bind to DNA to regulate transcription as well (227). The hnRNP K protein
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also interacts with many different host proteins and has a wide array of
functions in the nucleus and cytoplasm. Since the finding that hnRNP K
interacts with the replicase complex in SFV infection by Burnham et al,
hnRNP K has been found to interact with alphaviruses in every discovery
effort since (228). Differentially phosphorylated states of hnRNP K were
both found to have been increased in the cytosolic fraction after SINV
infection, though mostly the phosphorylated form interacts with the viral
replicase machinery containing the subgenomic RNA strand. Silencing of
hnRNP K also decreases the number of SINV infected cells at 6hpi,
indicating an important role for hnRNP K in the early stages of viral infection.
In studies performed by Bourai et al, the authors knocked down CHIKV
nsP2 interactants, which included hnRNP K (175). In this study, knockdown
caused decreased viral gene expression over time, and lower viral titer of
CHIKV. Varjak et al also found that hnRNP K knockdown inhibited CHIKV
and SINV infection by decreasing protein expression (173). Interestingly,
Varjak et al reported that the knockdown of hnRNP K did not affect SFV
viral titer and RNA synthesis over time and did not significantly affect SFV
viral protein expression until 8hpi, which correlated with the localization of
hnRNP K to areas of replication. Localization has not been characterized
previous to 6hpi, so the precise timing as to when hnRNP K, and really other
hnRNPs proteins, moves early in infection is unknown.
Unlike many of the other proteins reviewed here, the hnRNP K
protein has been evaluated in regard to its capacity to bind to and influence
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viral RNAs during infection. Specifically, as reported in LaPointe et al, the
hnRNP K protein interacts with a distinct interaction site on the subgenomic
vRNA (176). Disrupting this site with the incorporation of silent mutations
through the primary binding site caused lower viral titer in mammalian cells
and intriguingly increased structural protein expression. Both of these
studies validate the previous findings that hnRNP K is beneficial for old
world alphaviral infection. Overall, hnRNP K regulation most likely depends
on the phosphorylation status of the protein, and which alphavirus it
interacts with.

hnRNP M- Regulation of RNA Synthesis and Translation:
The hnRNP M protein has been indicated to be involved in the
splicing of immune gene transcripts, and it dampens the innate immune
response during some RNA viral infections (229, 230). During SFV
infection, hnRNP M was identified as a component of the replicase
complexes and was shown to colocalize with the viral replicase
machinery(173). Silencing hnRNP M increased viral gene expression
during SFV, CHIKV, and SINV infection, although the effect was minimal
with the Old-World alphaviruses. Viral titer was also increased as compared
to WT SFV infection. Nonetheless, hnRNP M knockdown only effected RNA
synthesis slightly by increasing at 8hpi.
As with hnRNP K, the specific binding affinity of the hnRNP M protein
have been directly evaluated. Indeed, reports from LaPointe et al. have
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found that hnRNP M directly interacts with the vRNA, primarily with the
subgenomic strand (176). As before with hnRNP K, disrupting the
interaction site by mutating the vRNA caused a decrease in hnRNP M
binding, inhibition of viral growth kinetics, and an increase in structural
protein expression.
LaPointe et al. reported some opposing results from the previously
discussed results from Varjak et al (176). After disruption of the interaction
site, the loss of interaction caused a reduction in viral titer in both
mammalian and mosquito tissue culture models, although no effect on
vRNA synthesis was observed. Viral protein expression, specifically the
structural proteins, was significantly increased. These opposing results
could be due to that the LaPointe studies used an interaction disruption
approach, whereas the Varjak approach of hnRNP M knockdown could
have impacted cell biology beyond viral infection, resulting in off-target or
indirect consequences on viral infection. Accordingly, we argue that
disrupting the interaction while leaving host biology unperturbed allows for
a more direct conclusions to be made regarding the importance of RBPs to
viral infection.

PCBP1/hnRNP E1- Unknown Promotion of Alphaviral Infection:
Along with hnRNP K, hnRNP E1 and E2 are the only hnRNPs that
have an RNA binding KH domain (231). The hnRNP E1 has been shown to
be involved in translational control of viruses like poliovirus, HPV and HCV
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(232-234). In 2013, Varjak et al found that PCBP1 does not colocalize with
SFV nsP3 proteins, however it is still important for infection (173). During
PCBP1 knockdown, viral gene expression was negatively impacted. Viral
growth kinetics were also decreased compared to WT SFV infection.
Silencing of hnRNP E1 caused a slight reduction in RNA synthesis early at
4hpi, however this effect seemed to disappear later in infection. Infections
with CHIKV and SINV also continued the trend of lower luciferase
expression with the lack of hnRNP E1 present. This data led the authors to
conclude that hnRNP E1 supports alphaviral infection (173). However, there
are no known experiments studying the effect of overexpression of this
protein, and there is not data on the role of hnRNP E1 as an RBP.

PTBP1/hnRNP I- Interaction with vRNA Regulations Translation:
PTBP1 (or hnRNP I as it is mainly called in this thesis) plays a role
in alternative splicing and can regulate RNA stability, replication, and
translation (235). HnRNP I preferentially binds to polypyrimidine tracts by
the four RNA binding domains and each domain has a high affinity for
sequences containing 15 to 25 pyrimidines (236). The third and fourth
binding domain of hnRNP I can even bind the same RNA and remodel the
structure to form a loop (237). As well as alternatively splicing host mRNA,
the majority of the functions of hnRNP I are enhancing RNA stability and
translation by binding and preventing RNA degradation (238). Not only does
hnRNP I promote host mRNA translation, but it has been shown to bind to
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the picornavirus IRES site and stimulate translation (239, 240). As well as
picornaviruses, hnRNP I is implicated in several viral infections including
being upregulated during ZIKV infection, interacting with several
coronaviruses, regulating hepatitis B virus, and interacting with the
influenza viral protein NS1 (241-245).
Studies out of our lab have characterized hnRNP I interactions with
alphaviruses as RBPs (176). Similar to the other characterized hnRNP
interactions with SINV, the hnRNP I protein interacts with SINV subgenomic
vRNA however its primary binding site is in the 3’ UTR region. The deletion
of this interaction from the vRNA causes diminished protein binding and
decreased viral growth in mammalian and mosquito cells lines. Despite
having lower viral titer and somewhat of a downward trend of vRNA
synthesis late during infection, viral structural gene expression significantly
increased (176). The characterization of the hnRNP I:vRNA interaction site,
and the impact of hnRNP I on SINV infection is a major focus of this
dissertation as described in detail in Chapter 3 (246).

Rationale
Alphaviruses cannot complete the lifecycle without RBP interactions,
whether they interact with the viral proteins or RNA. Many studies have sought out
to determine what RBPs are important to infection and characterize their role. In
addition, previous studies have used knockdown methods to disrupt RBP function
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which could harm cellular function to the point where it is not known if the effects
on alphavirus infection are due to the true ablation of this interaction or disrupting
the host.
Previously, we have found a distinct hnRNP I interaction site on the
subgenomic vRNA via CLIP-seq, as seen in Figure 2.1, and mutating the vRNA at
this site demonstrates that it is important to infection (176). Reduction of the
hnRNP I:vRNA interaction caused increased viral titer and decreased structural
protein expression. These observations led to question whether the hnRNP I
interaction was dependent on the primary sequence or the structure of the vRNA,
and how increased structural protein expression cause an overall decrease in viral
growth. Focusing on the hnRNP I interaction site for reasons described below, we
utilized a protein tethering method to characterize the hnRNP I interaction site
which allowed us to define the role of hnRNP I during infection without disturbing
host biology and effecting alphaviral infection by perturbing the host. Defining the
role of hnRNP I during infection is important as illustrating the molecular
interactions of alphaviruses provides more information about how the virus can
cause severe disease and can possibly lead us to innovative therapeutics and
vaccine candidates.
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Figure 2.1 Identification of the hnRNP:vRNA Binding Sites via CLIP-seq A
map of the SINV genomic RNA with relative site of the hnRNP I interaction
indicated in blue. The y-axis represents the statistical significance of the fold
enrichment at the nucleotide position, represented by the x-axis. Adapted from
LaPointe et al. 2018.
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To Bind With Specificity Without a Specific Binding Site- Developing the
Model System
While disrupting the vRNA hnRNP interaction site gives the ability to
determine the role of the specific hnRNP during infection without disrupting the
host, it still does not answer the question of exactly how the hnRNPs are affecting
infection. We implemented a protein tethering approach to determine if the impact
of hnRNP I bound to the vRNA was enough to abrogate the phenotypes
discovered, or if there was more to the sequence or structure of the vRNA. While
the interaction sites for hnRNP K and hnRNP M are in the subgenomic ORF,
fortunately the hnRNP I interaction site is in the 3’ UTR, and in a region that is not
imperative to infection. Thus, to determine the role of hnRNP interactions during
alphaviral infection by protein tethering, the hnRNP I site was chosen for its
sequence malleability. The hnRNP I interaction site is between the second and
third RSE, and this site could easily be replaced without interrupting too much of
the original viral sequence.
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CHAPTER 3
BINDING OF HNRNP I–VRNA REGULATES SINDBIS VIRUS STRUCTURAL
PROTEIN EXPRESSION TO PROMOTE PARTICLE INFECTIVITY 1

Summary
Alphaviruses cause significant outbreaks of febrile illness and debilitating
multi-joint arthritis for prolonged periods after initial infection. We have previously
reported that several host hnRNP proteins bind to the subgenomic Sindbis virus
(SINV) RNAs and disrupting the sites of these RNA–protein interactions results in
decreased viral titers in tissue culture models of infection. Intriguingly, the primary
molecular defect associated with the disruption of the hnRNP interactions is
enhanced viral structural protein expression; however, the precise underlying
mechanisms spurring the enhanced gene expression remain unknown. Moreover,
our previous efforts were unable to functionally dissect whether the observed
phenotypes were due to the loss of hnRNP binding or the incorporation of
polymorphisms into the primary nucleotide sequence of SINV. To determine if the
loss of hnRNP binding was the primary cause of attenuation or if the disruption of
the RNA sequence itself was responsible for the observed phenotypes, we utilized

1

This chapter is adapted from work previously published in Viruses, 2022, Volume 14, no. 7 with
the same title under a Creative Commons Attribution (CC BY). Westcott, C.E. et al., Binding of
hnRNP I–vRNA Regulates Sindbis Virus Structural Protein Expression to Promote Particle
Infectivity. Viruses, 2022. 14(7).
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an innovative protein tethering approach to restore the binding of the hnRNP
proteins in the absence of the native interaction site. Specifically, we reconstituted
the hnRNP I interaction by incorporating the 20nt bovine immunodeficiency virus
transactivation RNA response (BIV-TAR) at the site of the native hnRNP I
interaction sequence, which will bind with high specificity to proteins tagged with a
TAT peptide. The reestablishment of the hnRNP I–vRNA interaction via the BIVTAR/TAT tethering approach restored the phenotype back to wild-type levels. This
included an apparent decrease in structural protein expression back to the
baseline observed during wild type infection in the absence of the native primary
nucleotide sequences corresponding to the hnRNP I interaction site. Collectively,
the characterization of the hnRNP I interaction site elucidated the role of hnRNPs
during viral infection.

Introduction
Alphaviruses are positive-sense, single-stranded RNA viruses that have,
and will likely continue to, cause significant outbreaks of clinically severe disease
(5, 10, 247). A primary reason for the sustained emergence of mosquito-borne
viruses may largely be due to the wide geographical distribution of competent
mosquito vectors aggravated by climatological change and global trade, which
have led to the dissemination of vector mosquitos (4, 248, 249). Based on clinical
presentation, there are two subgroups of the alphaviruses, namely the encephalitic
and arthritogenic subgroups. Sindbis virus (SINV), Chikungunya virus (CHIKV),
Ross River virus (RRV), Semliki Forest virus (SFV), and Mayaro virus (MAYV) are
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all considered to be members of the arthritogenic group, and infection can result
in moderate to severe febrile illness often followed by long-term multi-joint arthritis,
which may persist for several years past the resolution of acute infection (11, 12,
250). While the arthritogenic alphaviruses are not typically as deadly as those of
the encephalitic subgroup, the arthritogenic alphaviruses still cause significant
burdens to community health systems and reduced quality of life to infected
individuals (7, 8). As stated earlier, due to the widespread distribution of vectorcompetent mosquitos, the majority of the world’s population is at risk for at least
one alphaviral infection. Despite there being significant clinical disease, there are
no FDA-approved treatments or safe, effective vaccines to limit the public health
burden of the alphaviruses.
The identification and study of host protein interactions with viral RNAs or
viral proteins is not a novel concept, and many studies have identified host factors
with known RNA-binding properties (52, 102, 169, 170, 172-175, 177, 179, 196,
223, 228, 251-254). While these prior efforts have established the importance of
these factors to alphaviral biology, many have overlooked the potential impact of
the host RNA-binding proteins engaging with the viral RNAs (vRNAs) on viral
biology and have instead utilized RNAi or gene knockout studies to evaluate the
importance of specific host factors to infection. In addition to not directly defining
the importance of the protein–vRNA interaction, this approach has the
disadvantage of potentially disrupting the host system if the target protein is deeply
involved in the regulation of host RNA biology (255-258). Thus, it remains possible
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that the knockdown or knockout of host factors essential to cellular homeostasis
may cause artefacts to viral replication.
Previously, we published a study that determined that there are several host
hnRNP proteins that directly bind to the SINV subgenomic vRNAs in a site-specific
manner (176). It was found that disrupting the hnRNP binding sites in the alphaviral
RNAs led to decreased growth kinetics, and surprisingly this phenotype correlated
largely with increased structural protein expression. Nonetheless, whether the
phenotypes observed following the mutation of the hnRNP interaction sites was
specifically due to the loss of hnRNP–vRNA binding or due to the mutations in the
primary nucleotide sequences or RNA secondary structures remained unknown.
The primary goal of this study was to determine whether the observed phenotypes
were genuinely ascribable to the loss of hnRNP protein binding through the
reconstitution of the protein–RNA interaction in the absence of the native
interaction site. To this end, we employed a modified protein tethering approach to
develop a mutant SINV, where a native hnRNP interaction site was replaced with
the bovine immunodeficiency transactivating response RNA element (TAR) (259261). As the inclusion of the BIV-TAR element would alter the primary amino acid
sequence of the target, we prioritized the hnRNP I interaction for evaluation, as the
hnRNP I interaction site is located in the SINV 3′UTR (176). Importantly, the
inclusion of the BIV-TAR element enabled the direct assessment of the importance
of the hnRNP–vRNA binding to SINV infection. Altogether, our data indicate that
the loss of hnRNP I protein binding to the vRNA is directly responsible for the
phenotype observed following the mutation of the native interaction site.
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Furthermore, the data from these efforts further define the biological and molecular
importance of the hnRNP proteins to alphaviral infection.

Materials and Methods
Tissue Culture Cells
BHK-21 (ATCC CCL-10) and HEK293 (ATCC CRL-1573) tissue culture
cells were cultured in minimal essential medium (MEM; Cellgro Mediatech, Inc,
Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS; Corning,
Corning, NY, USA), 1× penicillin–streptomycin (Pen/Strep; Corning, Corning, NY,
USA), 1× nonessential amino acids (NEAA; Corning, Corning, NY, USA), and lglutamine (Corning, Corning, NY, USA). HEK293T cells were cultured in
Dulbecco’s modified Eagle’s medium (Corning, Corning, NY, USA) supplemented
with 10% fetal bovine serum, 1× penicillin–streptomycin, 1× nonessential amino
acids, and 5 mM L-glutamine. All cells were maintained at 37 °C in a humidified
incubator at 5% CO2.
Where specifically noted, tissue culture dishes receiving HEK293 cells were
pre-treated with poly-l Lysine (Advanced Biomatrix, Carlsbad, CA, USA) to aid cell
adherence and prevent premature detachment during handling. Briefly, tissue
culture dishes were pre-treated with 0.1 mg/mL poly-l Lysine for 30 min at 4 °C.
After poly-l lysine treatment, the stock solution was removed and the wells were
briefly rinsed twice with 1× PBS and allowed to dry under sterile conditions prior to
seeding the dishes with HEK293 cells for use the next day.
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Sindbis Virus Mutant Construction and Preparation
To generate a SINV mutant with the native hnRNP I interaction site replaced
with the 21nt BIV-TAR element, we utilized a two-step mutational approach. First,
using site-directed mutagenesis, the primary nucleotide sequence of the native
hnRNP I interaction site of SINV.TE12-nanoluciferase, consisting of nucleotides
11,557 to 11,586, was replaced with a NotI restriction digestion site to generate
the hnRNP I interaction-deficient SINV.hnRNP IΔ (262). After sequencing to
confirm the veracity of the clone, a restriction enzyme/DNA ligase strategy was
utilized to insert the BIV-TAR element into the NotI (New England Biolabs, Ipswich,
MA, USA) site of the hnRNP I interaction-deficient subclone. The specific
sequence of the BIV-TAR element, including the NotI restriction enzyme
sequences

and

flanking

sequences,

was

5′-

gcggccgcaacactGGCTCGTGTAGCTCATTAGCTCCGAGCCtatcctgcggccgc-3′,
with the BIV-TAR-specific sequences capitalized for reference. The resulting virus,
SINV.hnRNP ITAR, was sequenced to confirm the presence of the BIV-TAR
element and to verify that the orientation of the element was correct.
All viruses utilized in this study were generated via the electroporation of invitro-transcribed RNAs derived from cDNA infectious clones, as previously
described (263). Briefly, approximately 10 ug of in-vitro-transcribed RNA was
electroporated into BHK-21 cells by a single pulse from a Gene Pulser Xcell
electroporation system set to deliver a single square-wave discharge of 125 V for
a period of 12.50 ms. After the development of significant cytopathic effects, the
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tissue culture supernatants were harvested and clarified of cell debris via
centrifugation prior to aliquoting and storage at −80 °C for later use.

Control and hnRNP ITAT Transfection of HEK293 Cells
To reconstitute the hnRNP I interaction via the BIV-TAR/TAT system and
test the importance of the hnRNP I interaction to SINV infection, HEK293 cells
were transfected with an expression plasmid encoding the full-length hnRNP I
protein with a c-terminal TAT peptide tag (pEXPR.hnRNPI-TAT) using
Lipofectamine 3000 (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA),
according to the manufacturer’s instructions. Transfections were conducted in a
12-well format at 80% confluence. Transfection efficiency was confirmed via initial
co-transfections of EGFP reporter plasmids (with efficiency estimated at >90%),
and hnRNP I-TAT expression was confirmed by western blot. Each well was
transfected with DNA–lipid complexes generated by mixing 0.5 ug DNA
supplemented with 2 μL of P3000 reagent and 1.5 μL of Lipofectamine 3000
reagent in separate volumes of 50 μL of Optimem (Thermo Fisher Scientific,
Waltham, MA, USA). Control transfections lacking the hnRNP I expression clone
were conducted in parallel. The cells were transfected in a minimal volume of 1 ml
of whole growth medium and allowed to incubate overnight prior to replacing the
media with fresh growth medium before continuing with further experimentation.
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Quantitative Immunoprecipitation of hnRNP I–vRNA Complexes
Transfected HEK293 cells were infected with either wild-type SINV or
SINV.hnRNP ITAR at a multiplicity of infection (MOI) of 5 plaque-forming units (PFU)
per cell in a 12-well format. At 16 h post-infection (hpi), the tissue culture
monolayers were harvested via gentle scraping and centrifugation at 300× g for
five minutes. The media were aspirated and the cells were washed with 1×
phosphate-buffered saline (PBS; Corning, Corning, NY USA) to remove
contaminating media. The washed cell pellets were gently resuspended in 1×PBS
supplemented with 1.0% formaldehyde and incubated under gentle agitation for 7
min. The cross-linked cell pellets were then recollected via centrifugation at 1000×
g for 3 min, and the supernatant was promptly removed and replaced with 1×PBS
supplemented with 0.25 M glycine to quench any excess formaldehyde. After a 5
min incubation, the cells were again collected via centrifugation as above and
resuspended in 400 μL of RIPA buffer (50 mM Tris pH 7.6, 150 mM NaCl, 1.0%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS) and lysed via brief sonication, as
previously described (176, 264).
The resulting lysates were clarified via high-speed centrifugation (5 min at
16,000× g) to remove insoluble debris, and subsequently immunoprecipitated with
10 μL of either anti-hnRNP I (anti-PTBP1; rabbit polyclonal; PA5-95949; Thermo
Fisher Scientific, Waltham, MA, USA) or anti-NALP1 (rabbit polyclonal; PA520005; Thermo Fisher Scientific, Waltham, MA, USA) as a nonspecific control.
Antibody complexes were then precipitated from the lysate via the addition of
paramagnetic protein G agarose beads. The beads were washed a minimum of
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five times prior to the elution of the immunoprecipitated materials via incubation at
70 °C for 30 min. The total RNA was extracted from the eluate using TRIzol reagent
(Promega, Madison, WI, USA), as indicated by the manufacturer’s instructions.
The purified RNAs were used as the inputs for the synthesis of cDNA for
analysis by qRT-PCR, as previously described. The relative quantitative
immunoprecipitation was determined by comparing the amount of viral RNAs
detected across the indicated experimental conditions, after normalization to the
sample specific inputs and nonspecific control immunoprecipitations as
determined by qRT-PCR.

Analysis of Viral Growth Kinetics
The viral replication kinetics were assayed using one-step growth kinetics
assays in HEK293 cells bound to poly-l lysine plates. After transfection the cell,
monolayers were infected with either wild-type SINV or SINV.hnRNP ITAR at an
MOI of 10 PFU per cell. After a one-hour adsorption period, the cells were carefully
washed twice with 1×PBS prior to the addition of whole medium supplemented
with 25 mM HEPES to enable the use of an automated liquid handling system
lacking a CO2 atmosphere. At the indicated times post-infection, the cell
supernatant was collected and stored at 4 °C, and fresh replacement media was
added. Viral titers were determined via plaque assay using BHK-21 cells overlaid
with a 2% Avicel (FMC, Philadelphia, PA, USA) suspension (in whole media). After
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a 30 h incubation period, the samples were fixed with 3.7% formaldehyde (in
1×PBS) and visualized by crystal violet staining.

Quantitative Analysis of SINV Structural Protein Expression
The assessment of structural protein expression was performed as
previously described, with several specific modifications (176). Briefly, HEK293
cells were cultured on poly-l-lysine-treated plates and transfected as described
above. The tissue culture monolayers were then infected with either wild-type SINV
or SINV.hnRNP ITAR at a MOI of 10 PFU per cell. After removal of the unbound
virus particles, fresh tissue culture medium was added and the cells were
incubated under normal conditions. At the indicated times post-infection, the
supernatant was removed and discarded and the cell monolayers were washed
with 1×PBS. Whole-cell lysates were then harvested by scraping in 1×PBS
supplemented with 0.15% Triton X-100 (Avantor; Radnor Township, PA, USA).
The lysates were collected in microcentrifuge tubes and frozen at −80 °C. After the
completion of the time course, the cell lysates were thawed, vortexed, and clarified
via centrifugation at 17,000× g for 3 min to remove insoluble materials. Equivalent
amounts of cell lysate, as confirmed by Bradford assay (Avantor; Radnor
Township, PA, USA), were then assessed using the Nano-Glo nanoluciferase
assay system (Promega, Madison, WI, USA) according to the manufacturer’s
instructions. The nanoluciferase activity was detected in a BioTek Synergy H1
microplate reader.
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Quantification of Viral RNA Synthesis or Accumulation and Particle Numbers
The lysates generated for the quantitative assessment of structural protein
expression, as described above, were treated with TRIzol reagent and extracted
using a Direct-zol-96 MagBead RNA kit (Zymol Research; R2102; Irvine, CA, USA)
via a Kingfisher Duo Prime automated nucleic acid extractor system. The
quantitative detection of the individual RNA species was accomplished using
strand-specific reverse transcription and standard curve qRT-PCR, as previously
described (176). The RNA levels were normalized to the 18S rRNA levels.
The particle numbers, as determined by genome equivalents per ml, were
quantitatively assessed similarly to those described previously, and as generally
described above, with two major differences. First, the input materials consisted of
tissue culture supernatants that had been boiled prior to the synthesis of genomespecific cDNAs. Second, the samples were not normalized to an endogenous
control transcript and were instead normalized through the use of equal volumes.

Purification of SINV Particles, Morphological Assessments via Transmission
Electron Microscopy, and SDS-PAGE
The concentration and purification of SINV particles were adapted from the
low-speed, low-temperature centrifugation protocol (265). Briefly, HEK293 cells
were cultured in 100 mm dishes infected (2 dishes per virus, per prep) to 95%
confluence. The monolayers were then infected with either wild-type or
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SINV.hnRNP ITAR at a MOI of 5 PFU units per cell. After the adsorption period, the
inoculum was removed and replaced with Virus Production Serum-Free Media
(VP-SFM; Gibco, Thermo Fisher Scientific, Waltham, MA, USA) supplemented
with 1× penicillin–streptomycin, 1× nonessential amino acids, and 5 mM Lglutamine. After a 20 h incubation period, the supernatants were harvested and
clarified via centrifuge to remove cell debris. The clarified supernatants were then
transferred to Oakridge tubes and the virus particles were gently pelleted via
centrifugation at 5300× g for 18 h at 4 °C. After centrifugation, the tubes were
promptly removed, the supernatant was carefully decanted, and the residual
moisture was gently blotted with a Kimwipe wrapped around a pipette tip. The
pellets were resuspended in HEPES-NaCl-EDTA resuspension buffer (HNE; pH =
7.5; 20 nM HEPES, 150 mM NaCl, 0.1 mM EDTA).
For the transmission electron microscopy (TEM) analysis, the SINV
particles were applies to Formvar- and carbon-coated 400-mesh copper grids and
stained with 1% uranyl acetate. The prepared grids were imaged using a JEOL
1010 transmission electron microscope operating at 80 kV. The images were
recorded via a Gatan Ultrascan 4000 CCD camera. The image processing and the
measurement of the particle diameter were performed in ImageJ.
The compositional assessment of SINV particles was accomplished via
standard SDS-PAGE with nonspecific Coomassie staining. Equal particle numbers
of either wild-type or SINV.hnRNP ITAR were boiled in 2× Laemmli buffer prior to
the resolution of proteins by molecular weight via SDS-PAGE on 10% pre-cast gels
(CriterionTM TGXTM; Bio-Rad Laboratories, Hercules, CA, USA). After
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electrophoresis, the gels were stained using Coomassie blue and visualized using
a flatbed scanner.

Quantitative Assessment of Viral Attachment
The HEK293 cells from untreated plates were scraped, aspirated, and
transferred into sterile microfuge tubes. After ensuring that the cells were evenly
resuspended, the cell aliquot was evenly divided and inoculated with either wildtype or SINV.hnRNP ITAR at a MOI of 0.1 PFU per cell and incubated with gentle
mixing at 4 °C to allow binding but not entry of the viral particles. After the
incubation period, one aliquot was immediately treated with TRIzol to generate an
input sample. The cells in the second aliquot were gently pelleted via centrifugation
at 300× g for 5 min at 4 °C, and extensively washed three times with excess
volumes of 1×PBS. Prior to being treated with TRIzol reagent, the cell pellets were
resuspended in an equivalent volume (relative to the input control) of whole media.
The total RNA from input and bound samples was extracted as described above,
and the number of viral particles bound to the host cells was determined via qRTPCR, as described above.
To determine the relative efficiency with which each viral particle population
bound to the host cell, the percent binding was calculated for each specific pair by
comparing the input and bound samples. A comparative analysis of binding was
performed by normalizing the percent bound to that detected for wild-type particles.
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For simplicity, comparisons were restricted to host cell derivation (as per mock or
hnRNP ITAT-transfected cells).

Deglycosylation of Viral Particles
Viral particles were deglycosylated via treatment with PNGase F
(Recombinant; New England Biolabs, Ipswich, MA, USA) under nondenaturing
reaction conditions. Briefly, equal amounts of viral particles were diluted into
PNGase nondenaturing reaction buffer, which was pre-prepared as close to 1× as
possible to prevent the destruction of the viral particles due to osmotic pressure.
The mixtures were then split into two parallel reactions, and 1% of total reaction
volume of PNGase F was added to one reaction. Both samples were then
incubated for a minimum of 18 h at room temperature prior to the determination of
the viral titer via serial dilution assays.

Statistical Analyses
All quantitative data shown are from a minimum of three independent
biological replicates, unless more replicates are specifically indicated. Data shown
represent the quantitative mean, with the error bars representing the standard
deviation of the means. Where appropriate, a statistical analysis of the ratios was
performed using variable bootstrapping, as described previously (266). Pairwise
statistical analyses were conducted using unpaired Student’s t-tests, with a
minimum threshold p-value of < 0.05 being considered statistically significant. A
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statistical analysis of the viral growth kinetics was accomplished using an area
under the curve (AUC) analysis.

Results
Developing a Protein Tethering System to Study the Impact of hnRNP I
Binding to SINV RNAs
On the basis of our prior data, we concluded that the disruption of hnRNP–
vRNA interaction sites, and ergo the loss of hnRNP–vRNA binding, resulted in
decreased viral growth kinetics, potentially as the result of increased structural
protein expression during SINV infection. However, from these data, conclusions
could not be made as to whether this phenotype was due to the direct loss of
hnRNP binding to the viral RNA, or due to some other consequence of mutating
the primary nucleotide sequences of the interaction sites themselves. As such, we
sought to develop a system by which the protein–RNA interaction of the hnRNP
proteins could be functionally and phenotypically restored in the absence of the
native interaction site to address whether hnRNP–vRNA binding or a cryptic
feature of the nucleotide primary sequence or structure was primarily responsible
for the observed defects in growth kinetics following the disruption of the hnRNP–
vRNA interaction sites.
In our previous study, we identified the hnRNP–vRNA interaction sites
between hnRNP K, hnRNP I, and hnRNP M and the SINV viral RNAs using nextgeneration sequencing approaches (176). The interaction sites for the hnRNP K
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and hnRNP M proteins were found within the structural ORF coding region of the
viral subgenomic RNA, whereas the interaction site for hnRNP I was determined
to be in the viral 3′UTR. Due to the constraints associated with manipulating the
coding regions of the viral RNAs, we elected to continue these studies by focusing
on the hnRNP I interaction site because of its location in the 3′UTR, as this region
of the genome has a greater degree of sequence plasticity.
Our previous approach to eliminate the hnRNP I interaction relied on the
deletion of the entire interaction site as identified by way of CLIP-Seq. Specifically,
in the original hnRNP I interaction mutant, nucleotides 11,545 to 11,608 were
deleted from the SINV 3′UTR. While the majority of this nucleotide range exists
between the repeat sequence elements (RSEs) 2 and 3, the tail end of the original
hnRNP I interaction deletion mutant included approximately 12 nt of RSE3. Thus,
as detailed above, the phenotype observed with the original hnRNP I interaction
site mutant could be due to either the loss of hnRNP I binding, the disruption of
sequences or structures important to the alphaviral biology, or a combination of
the two possibilities. As the primary goal of this study was to functionally dissect
the importance of hnRNP I binding from the viral RNA sequence, we developed a
new set of mutants to determine the specific impacts of the hnRNP I–vRNA
interaction. These mutants utilized a more focused definition of the hnRNP I
interaction site, as depicted in Figure 3.1A, to avoid altering the sequence and
putative structures of the RSEs.
To determine the specific impact of hnRNP I binding on SINV infection, we
employed a modified protein tethering approach that binds the hnRNP protein to
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the vRNA in a targeted manner in the absence of the native interaction site or
sequence. As diagrammed in Figure 3.1B, the native SINV hnRNP I interaction
site was replaced with the 20 nucleotide bovine immunodeficiency virus
transactivation response element (BIV-TAR) sequence to create SINV.hnRNP
ITAR. Importantly, in addition to ablating the native hnRNP I interaction site, the TAR
element enables the site-specific tethering of proteins tagged with a bovine
immunodeficiency transactivator (TAT) peptide motif by creating an RNA aptamer
/ structure that the TAT peptide recognizes and binds to with high affinity (259).
Thus, by expressing an hnRNP I protein tagged with the TAT peptide motif (hnRNP
ITAT) we may reconstitute the hnRNP–vRNA interaction, enabling direct
comparisons of infections with the native hnRNP I interaction, no hnRNP I
interaction, and a forced hnRNP I interaction to determine the explicit importance
of hnRNP–vRNA binding.
First, to confirm that the BIV-TAR/TAT system reestablished the interaction
between the viral RNA and hnRNP I, we quantitatively assessed the interaction via
immunoprecipitation. To this end, cells were either mock-transfected or transfected
with an expression plasmid encoding the hnRNP ITAT fusion protein, and then
infected with either wild-type SINV, SINV.hnRNP IΔ, or SINV.hnRNP ITAR. At 16 h
post-infection, the cells were crosslinked with formaldehyde and whole-cell lysates
were generated via the addition of detergent and gentle sonication (267). RNA–
protein complexes were immunoprecipitated via an hnRNP I-specific antibody, and
the amount of viral RNA that co-immunoprecipitated with hnRNP I was determined
via qRT-PCR. To ensure the specificity, the quantitative detection of the vRNAs

67

was normalized to parallel control immunoprecipitations using a nonspecific
antibody. As shown in Figure 3.1C, the deletion of the previously identified hnRNP
I interaction site (as per SINV.hnRNP IΔ and SINV.hnRNP ITAR) negatively
impacted the immunoprecipitation of SINV vRNA with anti-hnRNP I antibody by
approximately 2-fold in comparison with the wild-type SINV (SINV.WT). In contrast,
quantitative immunoprecipitations of hnRNP I protein–RNA complexes in lysates
generated from HEK293 cells that were transiently transfected with an expression
plasmid encoding the hnRNP ITAT fusion protein indicated that the BIV TAR/TAT
system was capable of reconstituting the hnRNP–vRNA interaction in the absence
of the native interaction site. Specifically, as shown in Figure 3.1D, the coimmunoprecipitation of the SINV vRNA with hnRNP I antibody was significantly
increased for SINV.hnRNP ITAR in the presence of hnRNP ITAT relative to SINV.WT
and SINV.hnRNP ITAR in the absence of hnRNP ITAT. Interestingly, the coimmunoprecipitation of SINV.WT vRNAs was modestly decreased in the presence
of hnRNP ITAT. The precise underlying the reasons behind this phenomenon are
unclear, but the potential causes of this decrease are speculated on in the
discussion section.
Altogether, these data confirm that the BIV-TAR/TAT system is a means by
which the interaction between the SINV vRNAs and the hnRNP I protein may be
restored in the absence of the native interaction site. Nonetheless, while confirming
that we may functionally dissect the binding from the vRNA primary sequence, the
specific consequences of restoring the hnRNP I–vRNA interaction on the viral
biology remain unaddressed.
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Figure 3.1. Protein tethering restores hnRNP I protein binding in the absence
of the native interaction site. (A) A nucleotide map of the hnRNP I interaction
site in the SINV TE12 3′UTR as defined by prior CLIP-Seq efforts. The specific
sequences targeted for deletion in this study are highlighted in red, and sequences
belonging to RSE3 (which were included in the original deletion mutant) are
highlighted in cyan. (B) A schematic diagram of the viruses used in these studies,
including wild-type SINV (SINV.WT) and the hnRNP I interaction-deficient mutants
SINV.hnRNP

IΔ and

SINV.hnRNP

ITAR,

which

incorporated

a

bovine

immunodeficiency virus transactivation response element (BIV-TAR) in lieu of the
native interaction site. The SINV repeat sequence elements (RSEs) are denoted
by cyan boxes with their relative number labeled inside, similarly the hnRNP I
interaction site, the SINV U-rich element and 19-nt 3′ conserved sequence element
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are indicated with red, purple, and gray boxes labeled with an I, U, or C,
respectively. Elements are drawn to scale. (C) Immunoprecipitation of vRNA–
hnRNP I complexes derived from mock-transfected HEK293 cells infected with the
indicated viruses. (D) Immunoprecipitation of vRNA–hnRNP I complexes derived
from hnRNP ITAT-transfected HEK293 cells infected with the indicated viruses.
Quantitative detection of vRNA relative to the SINV.WT level was accomplished
using qRT-PCR. Quantitative data shown are the means of three independent
infections or co-immunoprecipitations, with the error bars representing the
standard deviation of the means. Statistical significance, as determined by
Student’s t-test, is indicated above the specific comparisons (with * ≤ 0.05; ** ≤
0.01).
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Reconstitution of hnRNP I Binding Restores Growth Kinetics in Tissue
Culture Models of Infection
As the data above confirmed that the hnRNP I protein–RNA interaction
could be reconstituted in the absence of the native interaction site via the BIVTAR/TAT system, we next sought to examine whether hnRNP–vRNA binding
impacted the viral growth kinetics. Briefly, HEK293 cells were either mocktransfected or transfected with an expression plasmid encoding hnRNP I TAT, and
then subsequently infected with either SINV.WT or SINV.hnRNP ITAR at a
multiplicity of infection of 10 PFU/cell. Over a period of 24 h, the supernatants were
collected every six hours and the viral titer was quantitatively determined using
plaque assays. As shown in Figure 3.2A, the hnRNP I-binding-deficient mutant
SINV.hnRNP ITAR exhibited a statistically significant ~3.5-fold decrease in viral titer
relative to the wild-type SINV. In contrast, when the hnRNP I interaction was
restored through the BIV-TAR/TAT system in hnRNP ITAT-transfected cells, the
viral growth kinetics observed for SINV.WT and SINV.hnRNP I TAR were
comparable (Figure 3.2B).
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Figure 3.2. Restoration of hnRNP I binding results in wild-type-like growth
kinetics. The capacity of the hnRNP–vRNA interaction site mutant viruses to
replicate in HEK293 cells was assessed using one-step growth curves in (A) mocktransfected or (B) hnRNP ITAT-transfected cells. The titer was quantified using
standard plaque assays. Quantitative data shown are the means of at least three
minimum biological replicates, with the error bars representing the standard
deviation of the means. Statistical significance, as determined by the area under
the curve analysis, is shown above.
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Overexpression of hnRNP I Negatively Impacts Overall Growth Kinetics
Interestingly, despite using parallel conditions for both the control
transfection and hnRNP ITAT-transfected cells, the overall titers were lower for both
viruses in the hnRNP ITAT-expressing cells. The precise underlying cause of this
phenomenon is unclear; however, the overexpression of hnRNP I appears to
negatively impact cellular homeostasis, as observed via the cell division and
morphology.
An unfortunate consequence of the apparent toxicity of hnRNP I TAT
overexpression is that critical assessments of the one-step growth kinetics data
presented in Figure 3.2 do not enable the direct conclusion that reconstituting the
hnRNP I interaction restores the wild-type-like growth kinetics. Indeed, an
alternative conclusion could be that hnRNP ITAT overexpression negatively
impacted wild-type replication, while the replication of SINV.hnRNP I TAR was
unperturbed. To directly test whether SINV.hnRNP ITAR improved to wild-type
levels or wild-type deteriorated to meet SINV.hnRNP ITAR levels, we assessed the
impact of hnRNP ITAT expression on the parental hnRNP I interaction site mutant
SINV.hnRNP IΔ. As shown in Figure 3.3A, hnRNP ITAT expression uniformly
negatively impacted viral replication for all SINV mutants utilized in this study.
Importantly, while growth differences were readily observed between wild-type
SINV and both hnRNP I interaction-deficient viruses under mock-transfected
conditions (Figure 3.3B), in the presence of hnRNP I TAT, both wild-type SINV and
SINV.hnRNP ITAR replicated to similar extents, while SINV.hnRNP IΔ remained
phenotypically distinct and lower than wild-type SINV (Figure 3.3C). Thus, from
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these data, we are able to conclude that reconstituting the hnRNP I–vRNA
interaction genuinely restored SINV.hnRNP ITAR replication to wild-type levels.
From these data and the previous section, we are able to conclude that
replacing the native hnRNP I interaction site with the BIV-TAR element negatively
impacts the viral growth kinetics in highly permissive tissue culture models of
infection. More importantly, the reconstitution of the hnRNP–vRNA interaction via
the BIV-TAR/TAT system in the presence of hnRNP ITAT restored the wild-type-like
growth kinetics, ultimately providing strong evidence that the direct loss of the
interaction between the viral RNA and the hnRNP I protein is primarily responsible
for the previously established phenotype.
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Figure 3.3. Specific reconstitution of hnRNP I–vRNA binding restores wildtype growth kinetics in a mutant lacking the native interaction site. (A) Viral
titers of wild-type and hnRNP–vRNA interaction site mutant viruses SINV.hnRNP
ITAR and SINV.hnRNP IΔ at 24 h post-infection of mock and hnRNP ITAT-transfected
HEK293 cells infected at an MOI of 10 PFU per cell. (B) Comparative analysis of
the viral titer for each of the aforementioned SINVs in mock-transfected HEK293
cells relative to wild-type SINV. (C) Identical to (B), with the exception that the
HEK293 cells were transfected with hnRNP ITAT. Quantitative data shown are the
means of at least three minimum biological replicates, with the error bars
representing the standard deviation of the means. Statistical significance, as
determined by Student’s t-test, are indicated above the specific comparisons (with
* ≤ 0.05; ** ≤ 0.01; *** ≤ 0.001).
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Binding of hnRNP I Correlates with Translational Repression of the SINV
Subgenomic RNA
As demonstrated by the data presented in Figures 3.1 and 3.2, the BIVTAR/TAT system is a means by which the specific impacts of hnRNP I binding to
the viral RNAs may be assessed. Previously, we showed that disrupting the
hnRNP I–vRNA interaction site resulted in increased structural protein expression;
however, it was unknown whether the altered structural protein expression was
specifically due to the loss of hnRNP I binding or the mutation of a cryptic
regulatory element in the 3′UTR (176). To delineate the impact of the hnRNP I
binding on the structural protein expression, we utilized a reporter strain of SINV
that expresses nanoluciferase from the subgenomic RNA strand (Figure 3.4A).
Similar to what was previously reported, the loss of hnRNP I binding correlated
with a biologically and statistically significant enhancement of SINV structural
protein expression (Figure 3.4B). Indeed, at 16 hours post-infection (hpi), the
subgenomic gene expression during the SINV.hnRNP I TAR infection of HEK293
cells was significantly enhanced by approximately 4-fold relative to the wild-type
SINV. However, at early times during the infection, this effect was notably absent,
as at 4 hpi there was no difference in structural protein expression between
SINV.WT and SINV.hnRNP ITAR. At both 8 and 12 hpi, the wild-type SINV exhibited
slightly increased protein expression relative to SINV.hnRNP ITAR, yet only the
difference observed at 8 hpi was found to be statistically significant.
The examination of the structural protein expression during SINV infection
after the reconstitution of the hnRNP I interaction via the BIV-TAR/TAT system
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revealed that the loss of hnRNP I binding was directly responsible for the
enhancement of the structural protein expression late during infection. Specifically,
in cells expressing hnRNP ITAT there was no significant biological or statistical
difference between wild-type or SINV.hnRNP ITAR structural protein expression at
any time (Figure 3.4C). Nonetheless, as observed during the analysis of viral
growth kinetics above, the expression of hnRNP ITAT reduced structural protein
expression for both wild-type SINV and SINV.hnRNP ITAR.
Together these data suggest that hnRNP I-binding is tied to the regulation
of viral structural protein expression during infection, and that the enhancement of
the structural protein expression due to the loss of hnRNP I binding is timedependent and specific to the very late stages of infection.
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Figure 3.4. Restoration of hnRNP I binding abrogates the enhanced
structural protein expression observed late during infection. (A) A graphic
schematic of the nanoluciferase-based reporter strain derived from SINV TE12 that
expresses nanoluciferase in parallel with the SINV Capsid protein during the
translation of the subgenomic strand. (B) Mock-transfected or (C) hnRNP ITATtransfected HEK293 cells were infected with the designated virus and
nanoluciferase activity was quantified at the times indicated post-infection.
Quantitative data shown are the means of three independent infections, with the
error bars representing the standard deviation of the means. Statistical significance
as determined by Student’s t-test is indicated above the specific comparisons (with
* ≤ 0.05; ** ≤ 0.01).
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Binding of hnRNP I Does Not Contribute to the Regulation of Viral RNA
Synthesis
An established role for the hnRNP proteins during alphaviral infection
centers around viral RNA synthesis; however, it should be noted that these studies
relied upon RNAi-mediated knockdown strategies, which as described earlier
could lead to substantial off-target impacts on the cellular environment (173, 179,
217). Accordingly, to refine the understanding of the role of the hnRNP I protein in
viral transcription and replication, we examined the RNA synthesis profiles of wildtype SINV and the hnRNP I interaction-deficient viruses during infections of
HEK293 cells either mock-transfected or transfected with an hnRNP ITAT
expression plasmid. The detection of the individual viral RNA species was
accomplished using standard qRT-PCR detection using previously reported
methods over four-hour intervals from 4 hpi to 16 hpi.
As previously reported, the loss of the hnRNP I interaction did not
significantly alter the synthesis or accumulation of the individual viral RNAs, as
exhibited by the general RNA profiles observed for SINV.WT and SINV.hnRNP
ITAR with respect to time (Figure 3.5A,B) (176). In contrast, as shown in Figure
3.5C,D, both SINV.WT and SINV.hnRNP ITAR exhibited altered accumulation
profiles in the presence of hnRNP ITAT. In the presence of hnRNP ITAT expression,
the synthesis and accumulation of both the genomic and subgenomic RNA species
was negatively impacted, with average reduction rates of approximately 4- and 6fold, respectively, for SINV.WT and SINV.hnRNP ITAR. Nonetheless, despite the
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clear impact of the hnRNP ITAT expression on RNA synthesis, the overall
magnitudes of the impact were similar.
To enable a more direct comparison of the viral RNA species during
SINV.WT and SINV.hnRNP ITTAR analyses, we assessed the quantitative data for
the individual viruses using pairwise statistical analyses (Figure 3.5E,F). These
analyses revealed that only a single pairwise sample was statistically different
between SINV.WT and SINV.hnRNP ITAR, specifically the quantity of genomic viral
RNA at 16 hpi in the mock-transfected condition. All other comparisons, including
those for the subgenomic RNAs, were not different to any statistically significant
degree (with a minimum α ≤ 0.05 on a one-tailed analysis).
In summary, these data indicate that the synthesis and accumulation of viral
RNA species is not negatively impacted by the loss of hnRNP I binding or the
mutation of the native interaction sequence. However, the overexpression of
hnRNP I negatively impacted the viral RNA synthesis and accumulation in a
generalized manner.

80

Figure 3.5. Viral RNA synthesis is not impacted by the hnRNP–vRNA
interaction. Strand-specific quantitative analysis of the three SINV vRNA species
in mock-transfected HEK293 cells infected with (A) SINV.WT or (B) SINV.hnRNP
ITAR viruses at an MOI of 10 PFU per cell. (C,D) Identical to the previously
described panels, with the primary difference being that hnRNP I TAT-transfected
HEK293 cells were used. (E,F) Data from the previous panels reconfigured to allow
direct comparisons between the viruses in either cell condition. Quantitative data
shown are the means of three independent infections, with the error bars
representing the standard deviation of the means. Statistical significance as
determined by Student’s t-test is indicated above the specific comparisons (with *
≤ 0.05).
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Binding of hnRNP I is Important to the Viral Particle Function or Specific
Infectivity
Precisely how the loss of the hnRNP I protein–RNA binding negatively
impacts the SINV infection despite enhancing the structural protein expression has
always been an interesting yet puzzling question. Since structural protein
expression is directly linked to viral particle assembly, we sought to determine
whether or not the production of viral particles was negatively impacted by the loss
of hnRNP I binding (268, 269). To address this research question, we measured
the total particle production via the detection of genome equivalents by way of
qRT-PCR. Briefly, control-transfected and hnRNP ITAT-expressing cells were
infected with either SINV.WT or SINV.hnRNP ITAR, and tissue culture supernatants
were collected at 24 hpi. The number of viral genomic RNAs was then measured
via standard curve qRT-PCR to determine the number of viral particles. As shown
in Figure 3.6A, the loss of hnRNP I binding does not negatively affect the particle
production, as there is no difference in particle numbers between SINV.WT and
SINV.hnRNP ITAR in either the presence or absence of hnRNP ITAT. Consistent with
our above data the expression of hnRNP I reduced the particle production relative
to the control-transfected cells, as there was an approximately half-log decrease
in particle production for both SINV.WT and SINV.hnRNP ITAR.
While the production of total viral particles was seemingly unaffected by the
loss and restoration of hnRNP I binding, we hypothesized that the viral particle
function, as defined by the capacity of a viral particle to complete the viral lifecycle,
is negatively impacted by the loss of hnRNP I binding and subsequent structural
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protein overexpression. To define the functional potential of the viral particles
generated in the presence and absence of the hnRNP I interaction, we measured
the titer of the viral particles (Figure 3.6B) and determined the specific infectivity of
the particles by calculating the ratio of particles-per-PFU for the individual samples.
In this instance, a higher specific infectivity value means that it takes more particles
to make a single plaque forming unit, meaning the viral particle population has poor
infectious potential.
As shown in Figure 3.6C, SINV.WT particles derived from controltransfected cells exhibited an infectivity ratio of approximately 170:1 particles-perPFU, whereas SINV.hnRNP ITAR was significantly less infectious, with a particleper-PFU ratio of greater than 600:1. Nonetheless, when the hnRNP I protein–RNA
interaction was restored via the BIV-TAR/TAT system, the specific infectivity of
SINV.hnRNP ITAR significantly improved to a ratio of 200:1 and exhibited an
infectivity ratio highly similar to that of SINV.WT. It is notable that SINV.WT
particles exhibited a similar infectivity ratio regardless of whether they were
produced in control-transfected or hnRNP ITAT-transfected cells.
Altogether these data indicate that the particle functionality, as measure by
the infectious potential of the population, is negatively impacted by the direct loss
of hnRNP I binding and not the loss of specific primary nucleotide sequences or
secondary structures in the SINV 3′UTR. Moreover, these data infer that while the
particle production and viral titer may be generally reduced in systems that express
high levels of hnRNP I, the infectious potentials of wild-type viral particles are
unperturbed.
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Figure 3.6. Reestablishment of the hnRNP–vRNA interaction restores
viral particle infectivity. (A) Virus particles, as defined by the genome equivalents
per ml, derived from either mock or hnRNP ITAT-transfected HEK293 cells were
quantified via qRT-PCR. (B) Paired viral titer analysis of the samples examined in
(A) as measured using standard plaque assays. (C) Quantitative analysis of virusspecific infectivity, as measured by the ratio of particles per infectious unit, for the
samples described in the above panels. Quantitative data shown are the means of
three independent infections, with the error bars representing the standard
deviation of the means. Statistical significance as determined by Student’s t-test is
indicated above the specific comparisons (with * ≤ 0.05; **** ≤ 0.001).
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The Loss of hnRNP I Binding Does Not Negatively Impact Particle Assembly
or Structure
As reported above, the loss of hnRNP I binding negatively impacted the
specific infectivity of the viral particles. In light of these data, we hypothesized that
the overexpression of SINV structural proteins leads to the formation of viral
particles with decreased infectious potential, either through the formation of
aberrant multicore viral particles, the inclusion or exclusion of host or viral proteins,
or the production of irregular viral proteins during infection (as diagrammed in
Figure 3.7A). To test this hypothesis, we set about characterizing the viral particles
produced by wild-type SINV and SINV.hnRNP ITAR in the presence and absence
of hnRNP ITAT.
The production of multicore particles would readily explain our previous
observations, in that a single PFU would be composed of multiple genome
equivalents, as several nucleocapsid cores would be packed into an envelope,
resulting in a poor specific infectivity, as measured by the particle-per-PFU ratio
(270). To this end, we examined the morphologies of wild-type and hnRNP I
interaction-deficient viral particles via transmission electron microscopy (TEM). As
shown in Figure 3.7B, the overall morphologies of viral particles derived from
hnRNP I binding and nonbinding SINVs were highly similar, and multicore particles
were not observed. Curiously, the quantitative analysis of the particle diameter
indicates that viral particles derived in the absence of hnRNP I binding exhibited
increased heterogeneity, albeit to a minor extent.
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As the formation of multicore particles was not observed in the absence of
hnRNP I binding, we next characterized the protein composition of the viral
particles. Briefly, low-speed purified viral particles were denatured and analyzed
via SDS-PAGE and the total protein content was visualized by Coomassie staining.
As shown in Figure 3.7C, the viral particles produced in the presence and absence
of hnRNP I binding were highly similar, and no significant unexpected proteins
were observed. The quantitative analysis of the ratios of the viral glycoproteins to
capsid protein provides further evidence against the formation of multicore
particles, as the ratios between the particle populations are highly consistent.
Notwithstanding the products of these efforts being largely negative data in
regard to our hypothesis, these data were informative, as they effectively rule out
the possibility that gross particle defects were arising due to increased structural
protein expression. However, there could be minute differences in posttranslational modifications that could not be detected using an SDS-PAGE gel.
Nonetheless, from these data we cannot rule out that the malformation or
misprocessing of the viral structural proteins during assembly negatively impacts
the viral particle function.
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Figure 3.7. Loss of hnRNP I binding does not negatively impact the
viral morphology or composition. (A) A graphic model of several working
hypotheses as to how increased structural protein expression leads to poor particle
infectivity. (B) Representative TEM micrographs of wild-type or SINV.hnRNP ITAR
particles purified via low-speed low-temperature centrifugation. Below each
micrograph is a histogram of measured particle diameters with the mean and 95%
confidence intervals reported inset to each graph. (C) Concentrated SINV.WT and
hnRNP I interaction site deletion mutant viral particles were resolved via SDSPAGE gel and stained with Coomassie blue. Data shown are representative of
multiple independent viral preps. (C) The dashed line is indicative of where the gel
was cropped and merged to remove intervening lanes for the final presented
image.
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The Loss of hnRNP I Binding Negatively Impacts the Early Stages of
the Viral Lifecycle
Although the viral particles derived from the hnRNP I binding-deficient
mutant are less infectious, the mechanism behind why they are poorly infectious
is yet to be known. During the viral lifecycle there are several points with high
potential to influence the specific infectious potential of a viral particle, and
importantly these alphaviral lifecycle events can be parsed apart at certain points
to determine where in the lifecycle the particles are functioning poorly. As our data
above strongly indicates that the viral replication and gene expression are not
explicitly negatively impacted by the loss of hnRNP I binding, it can be reasonably
concluded that these events are not the primary defects leading to poor infectivity.
As such, we hypothesized that an earlier event in the viral lifecycle was responsible
for the observed deficits in specific infectivity.
To test our hypothesis, we quantitatively examined the first step of the viral
lifecycle, which is the viral attachment to the cell. To accomplish this, we exposed
HEK293 cells to either SINV.WT or SINV.hnRNP ITAR particles derived from
control-transfected or hnRNP ITAT-transfected cells at 4 °C for one hour to allow for
attachment without entry or internalization of the viral particles. Paired tissue
culture monolayers were then processed in parallel to generate input and bound
samples, with the bound samples being generated from exposed monolayers that
were extensively washed to remove unbound particles prior to RNA extraction. The
viral RNAs from the input and bound samples virus were quantitatively assessed
by qRT-PCR to determine the relative binding of the viral particles via the retention
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of genome equivalents. As shown by Figure 3.8A, the particles derived from
infections lacking the hnRNP I interaction bound approximately two-fold less to
cells relative to the particles derived from SINV.WT infection. Nonetheless,
SINV.hnRNP ITAR particles derived from hnRNP I TAT-transfected cells bound
equivalently to SINV.WT (Figure 3.8B).
As in order for a viral particle to be infectious it must first be able to attach
and enter into a host cell these data confirm our hypothesis that the loss of hnRNP
I binding negatively impacts an early event in the viral lifecycle, resulting in poor
specific infectivity. This assertion is evidenced by the reestablished particle
attachment, which correlates with the above restoration of the infectivity of
SINV.hnRNP ITAR in hnRNP ITAT-transfected cells.
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Figure 3.8. Loss of hnRNP I binding negatively impacts viral particle
attachment. Quantitative analysis of viral attachment via qRT-PCR of total RNAs
extracted from HEK293 cells that were incubated with viral particles derived from
either (A) mock-transfected or (B) hnRNP ITAT-transfected HEK293 cells.
Quantitative data shown are the means of three independent attachment assays,
with the error bars representing the standard deviation of the means. Statistical
significance as determined by Student’s t-test is indicated above the specific
comparisons (with * ≤ 0.05).
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Deglycosylation of the hnRNP I Mutant Particles Does Not Impact Their
Infectivity
The alphaviral entry pathway is initiated and governed by the viral
glycoproteins through their engagement with the host receptor during attachment
(270-272). As our data are indicative of a defect at the level of the cell attachment,
we hypothesized that the viral glycoproteins may be somehow altered in the
absence of hnRNP I binding due to the overexpression of structural proteins during
late infection. The viral glycoproteins are known to be post-translationally modified
during their maturation process, including being palmitoylated and glycosylated as
they traffic to the cell membrane for later envelopment of the nascent nucleocapsid
cores (60, 128, 162, 273, 274). As glycosylation has been previously identified as
a major contributor to cell attachment, we prioritized efforts to examine the impact
of glycosylation on the hnRNP I mutant particle function.
To define the extent to which glycosylation differences were contributing to
the observed deficits in particle function, we enzymatically deglycosylated
SINV.WT and SINV.hnRNP ITAR viral particles and assessed their infectious
potentials. Concisely, aliquots of the viral particles were either mock-treated or
treated with PNGase F under native protein conditions overnight, and the viral titer
was subsequently assessed. The deglycosylation of SINV.WT particles via
PNGase F negatively impacted the viral titer, as evidenced by a decrease of
approximately 5-fold (as depicted in Figure 3.9A). In contrast, there was little to no
decrease in the apparent viral titer when SINV.hnRNP ITAR viral particles were
treated with PNGase F. Indeed, comparing the relative effects of the
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deglycosylation on SINV.WT and SINV.hnRNP ITAR titer revealed that the
deglycosylation did not appreciably affect the specific infectivity of the
SINV.hnRNP ITAR particles (Figure 3.9B).
On the whole, these data strongly suggest that the differences in
glycosylation may be responsible for the underlying defects observed following the
loss of hnRNP I protein binding. Nonetheless, whether this is due to the absence
of glycosylation or the presence of faulty glycosylation is unknown at this time.
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Figure 3.9. The loss of hnRNP I binding negatively impacts the
glycosylation of the viral glycoproteins. (A) SINV.WT or SINV.hnRNP ITAR
viruses were incubated in the presence or absence of PNGase F overnight at room
temperature under nondenaturing conditions. After treatment the viral titer was
quantified and the change in viral titer is presented for each pairwise sample. (B)
The relative impact of deglycosylation, as determined by the average ratio of
treated and untreated samples. Quantitative data shown are the means of three
independent PNGase F assays, with the error bars representing the standard
deviation of the means. Statistical significance as determined by Student’s t-test is
indicated above the specific comparisons (with ** ≤ 0.01).

93

Discussion
As has been previously published, several host hnRNP proteins are known
to interact with the SINV vRNAs during infection, with the hnRNP K, I, and M
proteins interacting with discrete sites of the SINV subgenomic RNA (176). The
ubiquity and specificity of the hnRNP protein interactions was indicative of an
important role during the SINV lifecycle. Nonetheless, due to the involvement of
the hnRNP proteins in the synthesis and maturation of many cellular transcripts,
RNAi- or CRISPR-based approaches would undoubtedly perturb the underlying
cell system through the loss of hnRNP function. As shown here and published
previously by our lab, an approach that enables the assessment of the
contributions of the hnRNP proteins in the absence of an altered host system is to
target the hnRNP–vRNA interaction sequence without disrupting the coding
capacity of the virus. The application of this approach diminished the hnRNP–
vRNA interactions, leading to significantly decreased viral growth kinetics in tissue
culture models of infection. Curiously, the primary molecular defect associated with
the disruption of the hnRNP interactions was increased structural protein
expression, which positively correlated with decreased viral growth; however, the
precise underlying mechanisms behind these phenomena were unknown.
Altogether these observations raised several key questions, including the
following: (1) Are the observed phenotypes due to the loss of hnRNP binding or
due to disrupting the native RNA sequences? (2) How does the enhanced
structural protein expression in effect result in a decreased viral titer?

94

To address our research questions, we utilized a modified protein tethering
approach to reconstitute the hnRNP interaction in the absence of the native
sequence. Since the current protein tethering methodologies are largely
incompatible with use in coding regions, we focused our efforts on assessing the
hnRNP I–vRNA interaction, as the primary interaction site for hnRNP I is located
in the 3′UTR of the subgenomic RNA (176). Specifically, the BIV-TAR element was
incorporated into the vRNA at the site of the hnRNP I interaction site, where the
BIV-TAR element could act as a highly specific binding site for proteins such as
hnRNP I, provided the protein is tagged with a TAT peptide (259). To confirm the
capacity of the BIV-TAR/TAT system to reconstitute the hnRNP I–vRNA
interaction, we assessed the interaction via quantitative co-immunoprecipitation.
In the presence of hnRNP ITAT, the co-immunoprecipitation of the SINV.hnRNP ITAR
vRNA was equivalent to that of the wild-type interaction in the absence of hnRNP
ITAT and greater than that of the wild-type SINV in the presence of hnRNP ITAT. In
other words, more SINV vRNA was pulled down during the forced interaction
between SINV.hnRNP ITAR and hnRNP ITAT than that of SINV.WT in the presence
of hnRNP ITAT. The underlying cause of the reduced wild-type SINV coimmunoprecipitation is unclear, and potentially due to several mechanisms. First,
this could be due to the interaction between the BIV-TAR RNA and TAT fusion
peptide being a stronger interaction than the native hnRNP I and vRNA interaction,
resulting in greater occupancy and increased co-immunoprecipitation. In addition,
the overexpression of hnRNP I could interfere with the immunoprecipitation by
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reducing the amount of RNA–protein complex binding relative to the total hnRNP
I immunoprecipitation via an effective antibody dilution effect.
Regardless, this system allowed us to directly compare the phenotypes
observed between SINV infections with native hnRNP I interactions, those lacking
native hnRNP I infections, and those with a forced hnRNP I interaction. As such, it
is unsurprising that after confirming the validity of the BIV-TAR/TAT approach, we
then tested the effect of the hnRNP I tethering on the viral growth kinetics. As
observed before, there was a decrease in SINV.hnRNP ITAR titer compared to
SINV.WT in mock-transfected cells. However, this difference in infectious titer
between wild-type and SINV.hnRNP ITAR was not observed in hnRNP ITATtransfected cells, indicating that the tethering of hnRNP I was capable of restoring
the wild-type growth kinetics.
Despite alleviating the growth defect resulting from the loss of the native
hnRNP I interaction site, the overall titers for both the wild-type and interactiondeficient mutants were decreased in the presence of hnRNP ITAT relative to mocktransfected cells. This was despite an experimental design that included using the
same MOIs to infect either condition. Thus, the hnRNP I overexpression appears
to be deleterious to SINV infection in a generalized manner. This observation is
echoed by our assessments of viral gene expression, vRNA synthesis and
accumulation, and viral particle production. As alluded to above, the steady-state
levels of the hnRNP proteins, including hnRNP I, are likely important to the
homeostasis of the host cell, and altering the levels of hnRNP I upwards or
downwards may negatively impact the cytosolic environment. In support of this
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notion is the general observation that hnRNP ITAT-transfected cells looked
morphologically abnormal and less confluent when compared with cells that had
been mock-transfected. Accordingly, our leading hypothesis as to why viral titers
were reduced overall is that hnRNP I overexpression negatively impacts host cell
processes. In any case, the generalized impact of hnRNP I overexpression may
be negated by ensuring that phenotypic comparisons are made with those
between the viruses in a single transfection condition and not those between
transfection conditions.

Binding of hnRNP I is Specifically Important for the Regulation of Viral
Structural Protein Expression
Previously, we reported that disrupting the hnRNP I–vRNA interaction site
led to increased structural protein expression; however, this prior effort examined
viral gene expression in a limited manner late during infection, meaning the full
picture of the potential role of hnRNP I in the regulation of viral gene expression
throughout the lifecycle remained unknown. To enhance the understanding of the
role of hnRNP I in the regulation of viral translation, we examined the viral gene
expression with respect to time in systems with native hnRNP I interactions, those
lacking native hnRNP I infections, and those with a forced hnRNP I interaction.
In mock-transfected cells, there were no biologically significant differences
in viral structural protein expression at 4, 8, or 12 hpi. However, at 16 hpi the SINV
mutant lacking the hnRNP I interaction again exhibited enhanced structural protein
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expression. The timing of this effect may be indicative of the unavailability of the
hnRNP I protein to the vRNAs, as hnRNP I relocalization to the cytoplasm has not
likely occurred at these earlier stages of infection. As observed above for the viral
growth kinetics, there was no difference in structural protein expression between
SINV.WT and SINV.hnRNP ITAR in hnRNP ITAT-transfected cells, despite a
generalized decrease in viral structural protein expression. Hence, we conclude
that the hnRNP I protein binding to the viral RNA is important for the regulation of
the viral structural protein expression at late stages of viral infection.

Binding of hnRNP I is Dispensable to SINV vRNA Synthesis and
Accumulation
As the hnRNPs are RNA binding proteins that are involved in the processing
of many cellular RNAs, it was imperative to examine the potential impacts of
hnRNP I in viral RNA synthesis (230, 238, 255, 256, 275, 276). Previous studies
have shown that knockdown or silencing of hnRNPs will cause decreases in
alphaviral RNA synthesis; however, as discussed previously, this could be the
result of disrupting the host cell biology through the loss of hnRNP function (173).
As with the viral gene expression, our prior efforts examining the role of the hnRNP
proteins were limited to a singular time post-infection. Here, we expanded these
analyses by examining the impact of hnRNP I on SINV replication and RNA
synthesis with respect to time by using our model infection systems. Consistent
with our prior examination of hnRNP I interaction-deficient mutants, we observed
no explanative differences in RNA synthesis or accumulation for any of the vRNA
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species at any time post-infection in any of the conditions assessed. Collectively,
these data infer that under conditions of equal infectious units, the viral RNA
synthesis is unperturbed by the loss of hnRNP I binding.
Nonetheless, whether specific differences in viral RNA synthesis are
present at the very early stages of viral infection remains unknown. As a primary
difference between the native particles and those produced in the absence of
hnRNP I binding is decreased infectious potential, one could envision a scenario
where the viral RNA levels at the earliest stages of infection differ to a significant
extent. The inequality of the viral particle function would, a priori, suggest that the
viral RNA levels at the earliest instances of infection should differ by 2- to 3-fold,
as per the observed differences in attachment and specific infectivity. However,
these differences are not reflected by our data. There are several reasons as to
why these differences are not propagated to the times post-infection assessed in
this study, which were chosen on the basis of them representing times postinfection where all viral RNA species are readily detectable via qRT-PCR. First, it
is unclear as to whether the infectious particles would effectively deliver their RNA
cargos to the host system, thereby contributing them to the pool of cytoplasmic
viral RNAs from which replication may proceed. To control for this possibility, the
experimental designs were standardized to utilize equal numbers of infectious
units (as PFU) to create a level playing field between the hnRNP I mutant and wildtype SINVs. Secondly, the alphaviral RNA synthesis kinetics are inherently very
robust, and as such it remains possible that the RNA synthesis is capable of
overcoming any early deficits through the inherent momentum of replication.
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Overall, from our data we conclude that the loss of hnRNP I binding does
not significantly impact the RNA synthesis over time. However, as with our other
data, there is an observable general impact of the hnRNP I overexpression on the
vRNA synthesis.

Loss of hnRNP I Binding Results in the Production of Poorly Infectious Virus
Particles
All together, we can conclude that the phenotypic differences observed
following the mutation of the hnRNP I interaction site were due directly to the loss
of hnRNP I binding and not due to a loss of secondary RNA structures or primary
sequences. Nonetheless, while our first major research question had been
addressed, the question of how precisely an increase in structural proteins
negatively effects viral infection remained elusive. To address this ongoing
research question, we comparatively examined viral particles produced in the
presence and absence of hnRNP I binding via the BIV-TAR/TAT system.
A quantitative analysis of the viral particle production yielded an unexpected
result as the increased viral structural protein expression did not correlate with a
parallel increase in particle production. This observation was puzzling because
despite there being more structural proteins to make more viral particles, there was
no difference in particle production. Nonetheless, the differences in viral titer led to
the hypothesis that the particles made in the absence of hnRNP I binding were
less functional than wild-type viral particles. The virus-specific infectivity, as
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defined by the number of viral particles to infectious units, is a ready means by
which the functionality of the viral particles in total may be assessed. These data
presented above indicate that the viral particles produced in the absence of hnRNP
I binding are poorly functional relative to the wild-type particles. In short, when
there was no hnRNP I–vRNA interaction, many more particles were needed to
make one infectious unit, and when the hnRNP I interaction was restored through
the BIV-TAR/TAT system, the number of viral particles per infectious unit was
similar to that of the wild-type SINV. Not only do these data reinforce the conclusion
that the direct loss of hnRNP I binding is the specific cause of the observed mutant
phenotype, these data provide valuable insight towards the elucidation of the
underlying mechanism as to why there are decreased viral growth kinetics.
We have established so far that hnRNP I is important to the regulation of
the viral structural protein expression, and without that hnRNP I–vRNA interaction,
there is an influx of structural proteins at the later stages of infection relative to the
wild-type infection. Since alphaviral infections rely heavily on host processes to
develop mature virions, these excess structural proteins could overwhelm the host
biology and create a bottleneck in virus production. This in turn could create poorly
functioning viral particles via several different mechanisms, which we alluded to in
detail in the results section. Notably, many of our efforts were designed to identify
whether these overt defects were revealed wild-type-like phenotypes for the
particles produced in the absence of the hnRNP I interaction. Nonetheless, in this
case even the negative data were meaningful data, as they narrowed down the
potential causes of the defective particles.
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Despite being able to rule out the formation of multicore particles or
malformed particles, there was still no clear explanation of why these particles
were poorly infectious. The molecular data presented here indicate that an early
event of the viral lifecycle is negatively impacted by the loss of hnRNP I binding.
By turning to the beginning of the alphaviral lifecycle and examining the viral
attachment, we determined that the viral particles produced in the absence of
hnRNP I binding were less able to bind to the host cells in the tissue culture models
of infection. Importantly, this reduced attachment is ‘fixed’ when hnRNP I binding
is restored via the BIV-TAR/TAT system. The reduced attachment to the host cell
strongly suggested that the viral glycoproteins of the mutant particles were
stoichiometrically inferior, malfunctioning, or malformed. The examination of the
viral particle composition did not reveal altered capsid-to-glycoprotein ratios,
indicating that the mutant viral particles were likely not lacking viral glycoproteins
on the whole. As the alphaviral glycoproteins mature, they are post-translationally
processed prior to their incorporation into the viral particles (60, 162, 273). Of these
potential post-translational modifications, the glycosylation of the E1 and E2
glycoproteins has been previously established to directly influence the viral
attachment to the host cell, and the alphavirus glycosylation site mutants are poorly
infectious owing largely to the altered host cell attachment (156). Importantly, the
deglycosylation of SINV viral particles generated in the presence and absence of
hnRNP I binding reveals the difference in the glycosylation states to be a primary
difference between the two particle populations. As the SINV particles derived from
wild-type infection were sensitive to deglycosylation, whereas those generated in
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the absence of hnRNP I binding were insensitive, the defective particles formed
during enhanced structural protein expression may lack or possess erroneous
glycosylation profiles. Further studies are ongoing to determine precisely how an
increase in structural protein expression results in this phenotype, whether the
phenotype is the result of a bottleneck during processing or an active host
response to infection, and whether this phenotypic defect is caused by altered
glycosylation or a lack thereof.
It is worth noting that in addition to the defects in particle function related to
glycosylation, other defects may also be present and may contribute to the
phenotype observed during the loss of hnRNP I binding. These include aspects of
infectivity related to viral lifecycle events prior to and after host cell attachment. For
instance, our research has previously established that encapsidated host factors
and viral RNA features, such as the 5′ cap structure, influence the particle
infectivity (277, 278). Whether or not these phenomena are also altered in
response to the increased structural protein expression is unknown at this time.

Is hnRNP–vRNA Binding a Host Response to Infection, or the Recruitment
of a Pro-Viral Factor?
The sum of our observations raises an interesting question- is the
repression of the viral translation via hnRNP I binding beneficial or detrimental to
the virus? On face value, the molecular impacts of the hnRNP I binding, in that the
viral structural protein expression is reduced, are reminiscent of an anti-viral
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response by the host. However, the output of the increased structural protein
expression is the formation of poorly functioning viral particles, which infers that
the hnRNP I interaction is beneficial to the viral infection through a complex means
that maintains the functional integrity. The engagement of other host RNA-binding
proteins to the alphaviral RNAs has been established to be largely pro-viral. Thus,
we posit that the engagement of the hnRNP proteins to the viral RNAs is pro-viral
in nature due to the body of knowledge regarding alphaviral RNA-binding protein
interactions, as well as the summative phenotype resulting from the loss of hnRNP
I binding presented here. However, further work is needed to fully understand the
precise roles of cellular RNA-binding proteins during viral infection, including the
likely reality that the consequences of the RNA-binding protein function is
redefined during infection through post-translational modifications or the formation
of contextually novel ribonucleoprotein complexes on viral RNAs.
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CHAPTER 4
CONCLUSIONS AND FUTURE DIRECTIONS

Research Summary
Since alphaviruses are reliant on host proteins to complete the viral
lifecycle, the identification of these host / pathogen interactions and the
subsequent characterization of their importance to viral infection has been an
intensive area of study for decades. Many of these host protein interaction studies
were Protein:Protein interactions, but as more RBPs became apparent as host
interactants through these studies, the field shifted to focus on the role of the RBPs
via their potential RNA:protein interactions. For a significant period of time the
leading technological approaches consisted of knocking out or knocking down the
expression of the host factor prior to infection. As such, the majority of these
studies utilized RNAi or CRISPR based approaches to test the importance of the
RBP to infection; however, doing so likely harmed the normal cellular environment
and functions as many RBPs are critically essential to maintaining host gene
expression / homeostasis (169, 173, 174). Most hnRNPs have been studied during
normal function or during a disease state such as cancer; however, it is not known
if they serve these same “normal” functions during alphaviral infection. To
maneuver around the problem of disrupting the interaction without disturbing host
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biology, we and others pioneered an approach that consisted of incorporating
silent mutations, or sequence deletions in non-coding areas, to test the impact of
the interaction without modifying the host system (246). Interrupting the interaction
of the targeted RBPs caused decreased viral titer, and surprisingly, the primary
molecular defect was found to be increased structural protein expression. While
these early works identified the target proteins as important to alphaviral biology,
the precise mechanism behind this phenotype was unknown. Due to the nature of
the approach, several questions arose including whether the phenotypes observed
were due to a genuine loss of interaction or to the loss of an RNA sequence and /
or structure, and thus indirect to RBP binding. Additionally, the question as to how
increased structural protein expression could result in decreased viral titer
remained unanswered.
A major goal of this dissertation project was to determine whether the
phenotype associated with the mutation of the interaction site was due specifically
to the loss of hnRNP I binding. By employing a protein tethering system, we were
able to reconstitute the hnRNP I:vRNA interaction in the absence of the original
interaction sequence in the vRNA. We found that reconstituting this interaction via
the BIV-TAR system restored a wild-type like phenotype despite the absence of
the native RNA sequence or potential secondary structures. The results discussed
herein have led to the conclusion that hnRNP I directly binds to the vRNA, and the
phenotypic impact is directly due to the hnRNP binding and not dependent on the
loss of viral RNA structure or sequence.
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As stated above, another ongoing area of interest is the specific mechanism
as to how the loss of hnRNP I binding negatively impacted infection. As detailed
earlier, the primary defect associated with the loss of hnRNP I binding was
decreased viral particle specific infectivity. Or in other words, viral particles
produced in the absence of the hnRNP I interaction were inferior to wild type viral
particles in regards to cell attachment, and presumably entry. Extensive
characterizations of wild type, mutant, and reconstituted mutant viral particles
revealed that a potential defect in viral glycoprotein processing may be responsible
for the observed phenotype. From the data described earlier, it can also be
concluded that the increased structural protein expression due to the loss of
hnRNP I binding causes abnormal, incomplete, or nonexistent glycosylation,
culminating in poor particle function.

What is the Ultimate role of hnRNP I During Alphaviral Infection?
Unfortunately, despite clearly establishing the importance of hnRNP I
binding to viral infection, the direct role(s) the hnRNP I protein performs during
infection has not yet been completely elucidated, and how exactly hnRNP I binding
influences viral structural protein expression remains unknown. Nonetheless, there
are several potential mechanisms by which this might occur. For cellular
transcripts, the hnRNP I protein has been shown to increase RNA stability by
binding to the 3’ UTR, however, this mechanism is not likely the case during
alphaviral infection, as RNA abundance of the three viral strands is not affected by
the loss of hnRNP I binding (238). If the loss of hnRNP I was important to RNA
107

synthesis and replication, there would be a significant increase or decrease of RNA
levels. Even more, the hnRNP I protein is most likely not involved in the translation
of the nsPs, as more of the replicase complex would also lead to increased RNA
levels for all three species of viral RNAs.
During normal host function, hnRNP I typically enhances translation,
however the hnRNP I protein interacting with the viral subgenomic RNAs during
alphaviral infection negatively regulated protein expression. The hnRNP I protein
has been shown to be involved in the translational regulation of many different
viruses, and some of these instances are due to the binding of hnRNP I protein to
IRES elements in the 5’UTRs of the individual viruses (242, 279, 280). To date, it
is understood that the alphavirus subgenomic RNA is likely capped and no
functional 5’ IRES elements have been found (279). Nonetheless, as cap-mediated
translation has been shut off at the time of subgenomic translation due to the
inactivation of phosphorylated eIF2α by PKR, a potential role for the hnRNP I
protein during subgenomic RNA translation persists (200). While specifically
unknown for the alphaviruses, there are studies indicating that other RNA viruses
can use elements in their 3’ UTRs to direct translation via an IRES-like mechanism
(281). In alignment with this instance, perhaps the hnRNP proteins may act as a
complex to regulate translation by binding to the 3’ UTR and throughout the
subgenomic strand. If the hnRNP proteins function in this manner as a complex it
may also explain why the disruption of individual hnRNP interactions creates a
battery of mutants with similar phenotypes. The presence of a cryptic translational
element in the 3’UTR also creates a plausible explanation as to why the hnRNP
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proteins preferentially bind to the subgenome during infection. Nonetheless, the
fact that the loss of hnRNP I binding enhances translational activity is difficult to
reconcile with this possibility, and thus further examinations are warranted.
To study deeper aspects of the hnRNP I protein being involved in
translational regulation, the impact of hnRNP I binding should be examined outside
of the context of the viral RNAs during infection. For instance, the BIV/TAR
tethering system could be used to tether the hnRNP I protein to a nonspecific
reporter RNA, and the translational activity of the reporter quantified in the
presence and absence of viral infection. Due to the normal function of hnRNP I in
the absence of infection, one could assume that the translation of the reporter
strand would be increased with hnRNP I binding. Alternatively, if translation of the
reporter was decreased in the absence of infection, you could assume that hnRNP
I acts as a general translational repressor when bound in this context. If there was
a specific decrease of reporter translation during infection compared to increased
translation in the absence of infection, one could include that viral infection
perturbs or instills new function to the hnRNP I protein, as hnRNP I is shown to
increase translation, not inhibit it. Alternatively, if the hnRNP I tethering failed to
have any consequence outside of a viral context, it would suggest that the effects
of hnRNP I are specifically involved in the regulation of translation of the virus
through a cap-independent non-IRES element mechanism unique to Sindbis virus.
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Perspectives and Limits of Understanding
Picking a Dance Partner- Who or What Decides Viral RNA Binding
Specificity?
While host protein interaction studies have started to focus on specific RBPs
and their interactions directly with the RNA, an interesting question is raised when
multiple vRNAs are expressed from a single template- How might colinear RNAs
have different binding repertoires despite having identical sequences? For
example, hnRNP I selectively interacts with the subgenomic RNA and not the
genome, despite them being the same RNA sequence (176). Most likely, RBPs
have preferential binding sites due to their function during alphaviral infection, or
even the function of the RNA. Studies from several different labs have found that
different RBPs like hnRNP K, hnRNP I, and hnRNP M all preferentially bind to the
subgenomic vRNA in distinct interactions to promote alphaviral infection (176,
228). The La protein, one of the first host proteins to be found to interact with vRNA,
preferentially binds the 3’ end of the negative strand to most likely promote viral
replication (171). Additionally at the 3’ region, HuR binds to the URE and promotes
RNA stability (185, 186). At the opposite end, hnRNP A1 is involved in translation
by binding to the 5’ UTR of genomic vRNA (179, 223). While it is unknown exactly
why these interactions are specific to a particular RNA strand, we can hypothesize
that RBPs preferentially bind to the vRNA depending on the RBP function or even
the RNA function as well. As a large part of the genomic vRNA strand and the
minus strand do not translate, however the subgenomic strand does, it stands to
reason that they may have very different repertoires of RBPs. Additionally, the
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specificity conundrum may also be solved through the existence of dual occupancy
interaction sites, such as that posed by the SINV capsid protein and the host
hnRNP M protein (176, 264). In this instance binding specificity may be determined
by the presence of the competing RNA binding proteins during infection. It should
be noted that a secondary interaction partner for the cognate hnRNP I interaction
site has not been identified, although the explorations of RBP binding remains
woefully incomplete.

Backwards and in High Heels- Differential Host Functions and Requirements
As demonstrated by our data, and by others, RBP interactions are important
during mammalian infection, but also there are many RBP homologues in other
hosts of alphaviral infection, like mosquitoes. Proteins like HuR, the G3BP
homologue Rasputin, hnRNP A1, and PTBP1 all have been characterized during
infection of mosquito cell culture models (179, 185, 186, 193, 223, 246). These
studies have varied in whether they utilized knockdown or disrupted protein binding
by mutating the interaction site sequence, but almost always perturbing the RBP
or the RBP interaction negatively affected alphaviral infection. The effects seen
during mosquito cell line infection reflect the same effect in mammalian tissue
culture, and the conclusions from the vertebrate system are assumed to be true
for the invertebrate. However, it is not known if all RBP interactions have the same
role in multiple hosts or if there are host dependent RBP interactions therefore, it
is important to not apply the same conclusion to each system.
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On a similar note, within a single host system there can be considerable
variation in regard to RBP expression levels and patterns. This reality creates a
patchwork of host systems at the cellular level that may, or may not, support viral
replication should a critically necessary RBP be present or absent. A consequence
of this may be tissue or cellular restriction, in addition to the possibility that the viral
lifecycle is differentially regulated in different host cell systems.
Despite the ubiquity and essentiality of RBPs such as hnRNP I, the host
specificities, proclivities, and functions of the RBPs differ to a great extent across
and within the individual host. Thus, the importance of RBPs to viral infection
needs to be better characterized across all potential host systems.

Taking Center Stage- Location of RBPs
In most cases, the roles of the RBP during infection and the interaction
themselves are time dependent. During normal cellular function the majority of the
RBPs, especially the hnRNPs, spend the better part of their time in the nucleus,
and are shuttled back and forth to the cytoplasm during their normal functions in
host RNA biology. During infections with alphaviruses, many of these RBPs shuttle
out of the nucleus and stay in the cytoplasm around replication complexes for the
remainder of infection. Many also have certain roles either early or late during
infection, as experimental time courses have discerned the difference. The
relocalization of RBPs during infection could be due to a number of factors
including post-translational modifications like phosphorylation.
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Proteins like HuR and hnRNP K have been shown to have different roles
and localizations depending on the differential phosphorylation states of the
proteins. During normal biology, HuR can be phosphorylated and this is associated
with the localization of the protein. Studies by Dickson et al 2012 show that during
SINV infection, HuR is dephosphorylated, and it is hypothesized that this causes
the protein to relocate from the nucleus to the cytoplasm during infection, in which
the vRNA sequesters HuR away like a sponge (188). Both forms of
unphosphorylated and phosphorylated hnRNP K were found in the cytosol during
SINV infection, although mostly the phosphorylated form interacted with the
replicase machinery and subgenomic vRNA (228). It has been shown that hnRNP
K has multiple phosphorylation sites, and these are all important for the different
functions and locations of hnRNP K. While we do know that hnRNP K is
phosphorylated during infection, we do not know the specific role the
phosphorylated protein plays. In normal host biology, phosphorylation states can
determine the role of RBPs, almost like a switch, and effects binding to RNA or
shuttling out of the nucleus. These differential states most likely also effect
alphaviral infection, although they have not been described or studied in detail.

Don’t Say ‘Break a Leg!’- Perspective Role of RBPs During Infection
One of the biggest questions that arises from studies of host proteins during
alphaviral infection is whether these interactions are pro- or anti-viral.
Unfortunately, despite these interactions being researched for decades, the
answers to this question are extremely nuanced. Depending on the study, the
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alphavirus, and the way of inhibiting the RBP, the effect could be interpreted as
being either. For instance, HnRNP U has been shown to be antiviral and activate
type-I IFNs during infection with DNA and RNA viruses, although this specific
interaction has not been shown for alphaviruses (282). In Varjak et al, the
knockdown of hnRNP M proved to be beneficial by increasing viral genomic and
subgenomic expression and viral titer; however, studies from our lab have shown
that disrupting the interaction with vRNA causes decreased viral titer, albeit while
increasing structural protein expression (173, 176). Thus, while both studies
concur that hnRNP M is important to infection, the precise nature of the interaction
to alphaviral infection is nuanced. There may also be roles for the hnRNPs to
repress innate immune sensing, as it binds to vRNA sensing proteins and it
represses splicing and processing of immune transcripts. In the majority of studies,
RBPs act in a pro-viral way since interrupting the interaction causes decreased
viral growth along with other phenotypes as described in previous chapters. The
dual evolution of host protein and alphaviral interactions have caused an already
complex system to become more multifaceted. Alphaviruses have most likely
hijacked the host system to benefit infection, although some RBPs still may have
innate or intrinsic antiviral properties.

Future Directions
The project described in detail here characterizes the interaction between
the host hnRNP I protein and the vRNA; however, as we have found there are
many more RBP interactions with SINV vRNA that need to be characterized in
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depth. In our previously published research, we found that disrupting the
hnRNP:vRNA interactions decreased viral titer and despite hnRNP K, hnRNP I,
and hnRNP M all having distinct interaction sites they all manifested a similar
phenotype upon the disruption of their binding site. This led to the hypothesis that
hnRNPs are possibly acting as a complex to regulate subgenomic translation.

All Together Now- hnRNP Complexes During Infection
HnRNPs, for example hnRNP I, have been previously shown to interact with
each other, as the hnRNP K protein has a K-interactive (KI) region that acts as a
docking site for other proteins (283). Determining if RBPs act as a complex would
be beneficial for other alphaviral infections as well, as the interaction sites do not
overlap among the different viral species. As found by Gebhart et al, there are
many conserved RBP interactions, however they are not all in the same distinct
region (177). An approach to determine this is to isolate the RNA:protein
complexes by the RNA, and determine if there are multiple proteins attached, for
example as in hnRNP K and hnRNP I together, by immunoprecipitation or mass
spectrometry. Another interesting approach would be to replace the TAT peptide
tagged hnRNP I with another RBP such as hnRNP K or hnRNP M and determine
if the interaction is from a complex or from a singular protein. For this approach,
similar experiments like the ones described in Chapter 3 would be executed: viral
growth, RNA levels, and structural protein expression to determine if forcing the
‘new’ hnRNP would restore the phenotype back to wild-type like levels. Although
the hnRNP K and hnRNP M interactions were in the coding regions, the new TAT
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fused peptides would still have to be in the 3’ UTR, as replacing the original hnRNP
interaction sites with the BIVTAR sequence would disrupt critical coding regions of
the structural proteins. However, because the original binding site would not be in
the same location of the forced interaction, the interactions may not be equivalent.

Changing the Tempo of Structural Gene Expression Negatively Impacts
Glycosylation
Although the work here establishes that hnRNP I interaction with the vRNA
is important to infection, it still is unknown how exactly increased structural protein
synthesis causes aberrant glycosylation. One possible mechanism is that an
increase of structural proteins could overwhelm host processes, as alphaviruses
are reliant on the host to glycosylate the viral glycoproteins prior to assembly of
the viral particle (162). This could lead to several outcomes affecting the
glycosylation profile including the partial or full lack of glycosylation, or erroneous
or immature glycosylation of the viral glycoproteins. As seen in the data described
in Chapter 3, increasing structural protein expression by disrupting the
hnRNP:vRNA interaction site caused a loss of sensitivity to the deglycosylation of
the viral particles by PNGase F treatment implying that the glycosylation status of
the viral particle was already disturbed. Concluding from these data, one could
imply that there could be no glycosylation residues present in the mutant particles,
that the particles could be partially glycosylated resulting in the incorporation of
incomplete or nonfunctional glycoprotein spikes, or that the host glycosylation
machinery is transferring immature glycans that natively decrease infection and
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attachment to cells. Determining exactly how glycosylation is disrupted in the
hnRNP I viral mutant would be beneficial to understanding the role of hnRNP I
during infection. The isolation and digestion of the viral glycoproteins of the wild
type and hnRNP I interaction deficient mutants for mass spectrometry could initially
tell us if the viral glycoproteins have aberrant or deficient glycosylation states. If a
molecular bottleneck is to blame, then the addition of either the oligosaccharide
parts (to enhance metabolic availability) or the overexpression of Nglycosyltransferase enzymes during the infection with the hnRNP I interaction
deficient virus could rescue viral attachment and growth kinetics. While this may
not determine the precise effect of the loss of hnRNP I binding on viral infection, it
does elucidate how the interaction may impact glycosylation and its role to
infection.
Glycosylation modifications are important for functional viral glycoproteins
as they contribute to the correct folding of the glycoproteins to form a fully
functional viral particle. In fact, a study from Ren et al 2022 confirms this notion by
interrupting the interdimer interaction that is between E2 of one heterodimer and
E1 of another heterodimer via mutating six E2 amino acid residues at the
interdimer interface (284). Very similar to the results we have found, the interdimer
interaction disruption caused nonspherical and fragile viral particles by disrupting
the folding of the trimeric spikes of the glycoprotein dimers. Revertant site mutants
interfered with the glycosylation sites of the viral glycoproteins, and these revertant
mutations allowed for better protein folding and glycoprotein trimerization in the
mutants (284). Not only is glycosylation important for the correct folding of the
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glycoproteins, but it is important for attachment to the host cells. Attachment and
infection of cells is important for virulence, as mouse models infected with RRV
mutants lacking glycosylation have reduced disease and increased viral clearance
(161, 285). Glycosylation is closely linked to virulence and recognition by the host
immune system. Given the impact of the loss of hnRNP I binding on glycosylation,
it is important to continue this interaction which may lead to possible vaccine
candidates. However, glycosylation states may also contribute to host tropism, as
expression of receptors that bind to N-linked glycosylation on nonpermissive cells
will allow for alphaviruses to infect them (286).

Concluding Remarks

Host RBPs are critical for a successful alphaviral infection. While the direct
consequences of many host RBPs binding to the viral RNAs remains unknown to
infection, the work in this dissertation elucidates the role of hnRNP I binding to the
subgenomic vRNA and defines how the hnRNP I:vRNA interaction impacts
infection. Through the results presented here, we can conclude that hnRNP I
regulates structural protein translation, although the exact mechanism(s)
underlying this phenomenon are yet to be fully discovered.
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ARE

AU-rich element

AUC

area under the curve

AUD

Alphavirus Unique Domain

BIV-TAR

Bovine Immunodeficiency virus Transactivation RNA Response
element

CHIKV

Chikungunya virus

CLAMP

Cross-link-assisted mRNA purification

CLIP-seq

Cross-linking and immunoprecipitation sequencing

CP

Capsid

CSE

Conserved sequence element

EEEV

Eastern Equine Encephalitis Virus

GFP

Green fluorescent protein

gRNA

Genomic RNA

HCV

Hepatitis C virus

hnRNP

Heterogenous nuclear ribonucleoproteins

hpi

Hours post infection

HPV

Human papillomavirus

HVD

Hyper Variable Domain

IFN

Interferon
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KI

K-interactive

MALDI-TOF

Matrix-assisted laser desorption / ionization-time of flight

MAYV

Mayaro Virus

MOI

multiplicity of infection

MS

Mass spectrometry

NSAIDs

Non-steroidal anti-inflammatory drugs

NW

New World

ORF

Open reading frame

OW

Old World

P:P

Protein:Protein

PFU

plaque forming units

qRT-PCR

Quantitative Real Time Polymerase Chain Reaction

RBP

RNA binding proteins

RDRP

RNA-dependent RNA polymerase

RepC

Replicase complex

RRM

RNA recognition motif

RRV

Ross River virus

RSE

Repeated sequence element

SFV

Semliki Forest virus

sgRNA

Subgenomic RNA

SINV

Sindbis virus

TAT

bovine immunodeficiency transactivator

TEM

transmission electron microscopy
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TF

TransFrame

TNF

Tumor necrosis factors

URE

U-rich element

UTR

Untranslated region

VEEV

Venezuelan Equine Encephalitis Virus

vRNA

Viral RNA

WEEV

Western Equine Encephalitis Virus
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